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ABSTRACT 
Intracytoplasmic sperm injection (ICSI), as well as other micromanipulation assisted reproductive 
technology methods, such as physiologic ICSI (PICSI) and intracytoplasmic morphologically 
selected sperm injection (IMSI), are routinely used in many fertility laboratories around the world. 
An integral part of these methods is the manipulation of spermatozoa in preparation of the injection 
into the oocyte. It is common practice to place prepared spermatozoa in a viscous holding medium 
to facilitate the handling, manipulation and slowdown of spermatozoon movement during the 
immobilization and injection processes of ICSI. The possible effect of these holding mediums on 
basic semen parameters, as well as the sperm deoxyribonucleic acid (DNA) and structural integrity 
of spermatozoa, is of importance.  
Hamilton Thorne IVOS® developed an automated software solution for live sperm morphology 
evaluation under high magnification, called IMSI StrictTM. It combines Tygerberg Strict Criteria 
morphological classification of human spermatozoa with motile sperm organelle morphology 
examination (MSOME) and provides software-based categorization. The IMSI StrictTM software 
was developed to aid in the IMSI spermatozoon selection process that enables objective 
classification of spermatozoa to remove inter-technician variation. For good optics and 
spermatozoon evaluation in IMSI StrictTM, spermatozoa need to be moving very slowly or be 
immotile, but still viable. This can be achieved by placing spermatozoa in a viscous holding 
medium, either polyvinylpyrrolidone (PVP) or SpermSlowTM, sometimes for a substantial time 
period. Before marketing the clinical use of IMSI StrictTM, the possible toxicity or deleterious effect 
of PVP and SpermSlowTM on spermatozoa needs to be excluded.  
The primary objective of this study was to evaluate the effect of PVP and SpermSlowTM on human 
spermatozoa after different exposure times using a viability stain, CASA motility and kinetic 
parameters, chromatin packaging analysis (CMA3 staining analysis) and DNA fragmentation 
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analysis (TUNEL analysis). The secondary objective was to evaluate the effect of PVP and 
SpermSlowTM on human spermatozoa‟s ultrastructure with Transmission Electron Microscopy.  
This prospective analytical study was conducted at Drs Aevitas Fertility Clinic (Vincent Pallotti 
Hospital, Cape Town, South Africa) as well as the Fertility Unit at Tygerberg Hospital (Cape Town, 
South Africa) between July 2013 and October 2014. A total of 90 separate (no duplication) semen 
samples were analysed for the quantitative analysis (primary objective) and 1 sample for the 
descriptive analysis (secondary objective).  
Results showed that although PVP and SpermSlowTM treated sperm outcomes often differed 
significantly after typical statistical analysis, clinically these two mediums were shown to be 
equivalent (using a specific statistical test for equivalence) for the tested outcomes. PVP and 
SpermSlowTM had no detrimental effect clinically on sperm viability, motility parameters, chromatin 
packaging and DNA fragmentation rate. The secondary investigation indicated that SpermSlowTM 
might exert a disintegrating effect on various sperm membranes, and as a secondary consequence 
of the eventual necrotic process, alteration of chromatin and cytoskeletal components. PVP 
medium on the other hand did not show these disintegrating effects. This finding needs to be 
further investigated since only one semen sample was evaluated. 
Based on this study‟s results, either PVP or SpermSlowTM can be used for IMSI StrictTM purposes. 
However, the study did not include the technical aspects of the usage of PVP and SpermSlowTM.  
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OPSOMMING 
Intrasitoplasmiese sperm inspuiting (ICSI), sowel as ander mikro-manipulasie voortplantings 
tegnieke, soos fisiologiese ICSI (PICSI) en intrasitoplasmiese morfologies geselekteerde sperm 
inspuiting (IMSI), word in baie fertiliteitsklinieke regoor die wêreld gebruik. 'n Integrale deel van 
hierdie metodes is die manipulasie van spermatosoa ter voorbereiding van die inspuitproses. Dit is 
algemeen om voorbereide spermatosoa in 'n viskose medium te plaas om die hantering, 
manipulasie en vertraging van spermatosoön beweging tydens die immobilisasie en inspuitproses 
van ICSI te fasiliteer. Die effek van hierdie mediums op basiese semenparameters, sowel as die 
sperm deoksiribonukleïensuur (DNS) en strukturele integriteit van spermatosoa, is van belang.  
Hamilton Thorne IVOS® het 'n sagteware oplossing, IMSI StrictTM, vir lewende sperm morfologie 
evaluering onder hoë vergroting ontwikkel. Hierdie sagteware bied sagteware-gebaseerde 
morfologiese klassifikasie deur die Tygerberg streng kriteria morfologiese klassifikasie met 
beweeglike spermorganel morfologie ondersoek (MSOME) te kombineer. Die IMSI StrictTM 
sagteware is ontwikkel om die objektiewe klassifikasie van spermatosoa vir IMSI spermatosoön 
seleksie moontlik te maak. Spermatosoa moet baie stadig beweeg of immotiel, maar steeds 
lewensvatbaar wees om goeie optika en spermatosoön evaluering vir IMSI StrictTM te verseker. Dit 
sal bereik kan word deur spermatosoa in 'n viskose medium, hetsy PVP (“polyvinylpyrrolidone”) of 
SpermSlowTM, vir 'n aansienlike tydperk te inkubeer. Voordat IMSI StrictTM vir kliniese gebruik 
bemark kan word moet die moontlike toksisiteit of nadelige effek van PVP en SpermSlowTM op 
spermatosoa uitgesluit word.  
Die primêre doel van hierdie studie was om die effek van PVP en SpermSlowTM op menslike 
spermatosoa na verskillende inkubasie tye te evalueer deur ŉ lewensvatbaarheid kleuring toets, 
twee sperm DNS toetse (CMA3 en TUNEL) en rekenaar geëvalueerde sperm beweeglikheid toetse 
te gebruik. Die sekondêre doel was om die effek van PVP en SpermSlowTM op menslike 
spermatosoa se ultrastruktuur deur middel van Transmissie Elektronmikroskopie te evalueer.  
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Hierdie studie is by Drs Aevitas Fertiliteitskliniek (Vincent Pallotti Hospitaal, Kaapstad, Suid-Afrika) 
sowel as die Fertiliteitseenheid by Tygerberg Hospitaal (Kaapstad, Suid-Afrika) tussen Julie 2013 
en Oktober 2014 uitgevoer. 'n Totaal van 90 semenmonsters vir die kwantitatiewe analise (primêre 
doel) en een vir die beskrywende analise (sekondêre doel) is ontleed.  
Resultate het getoon dat alhoewel PVP en SpermSlowTM geïnkubeerde spermuitkomste dikwels na 
ŉ tipiese statistiese analise betekenisvol verskil, hierdie twee mediums vir die geëvalueerde 
uitkomste klinies ekwivalent (bepaal deur middel van spesifieke statistiese toetse vir ekwivalensie) 
is. Die mediums het ook nie klinies 'n nadelige effek op sperm lewensvatbaarheid, beweeglikheid 
parameters, chromatien verpakking en DNS fragmentasie koers getoon nie. Die sekondêre 
ondersoek het getoon dat SpermSlowTM hoofsaaklik 'n effek van disintegrasie op verskeie 
spermmembrane getoon het. Hierdie nekrotiese proses kan lei tot verandering van chromatien en 
sitoskelet komponente. PVP medium het egter nie dieselfde disintegrerende effek getoon nie. 
Hierdie bevinding moet egter verder ondersoek word, aangesien slegs een semenmonster 
geëvalueer is. 
Alhoewel hierdie studie nie die tegniese aspekte van die gebruik van PVP en SpermSlowTM 
geëvalueer het nie, kan aanbeveel word dat óf PVP óf SpermSlowTM op grond van geëvalueerde 
uitkomste tydens die IMSI StrictTM sperm seleksie proses gebruik word.  
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CHAPTER 1 
Background Information and Literature Review 
 
Intracytoplasmic sperm injection (ICSI), as well as other micromanipulation assisted reproductive 
technology (ART) methods, such as physiologic ICSI (PICSI) and intracytoplasmic morphologically 
selected sperm injection (IMSI), are routinely used in many fertility laboratories around the world. 
An integral part of these methods is the manipulation of spermatozoa in preparation of the injection 
into the oocyte. It is common practice to place prepared spermatozoa in a viscous holding medium 
to facilitate the handling, manipulation and slowdown of spermatozoon movement during the 
immobilization and injection processes of ICSI. The possible effect of these holding mediums on 
basic semen parameters, as well as the sperm deoxyribonucleic acid (DNA) and structural integrity 
of spermatozoa, is of importance.  
 
1.1  History and development of ICSI 
The development and successful introduction of ICSI into clinical practise was a breakthrough in 
ART and has revolutionized the treatment of male factor infertility (Tarlatzis and Bili, 1998). This 
micromanipulation technique entails the mechanical insertion of a single selected spermatozoon 
directly into the cytoplasm of a mature oocyte after ovarian superovulation and oocyte retrieval.  
Initially this technique was used in veterinary medicine to investigate the different steps during 
fertilization. The first procedure where a spermatozoon was injected into an oocyte was done by 
Hiramoto (1962) in the sea urchin. In 1966, Lin reported the first mammalian oocyte injection 
procedure where mouse oocytes were microinjected. Ten years later, Uehara and Yanagimachi 
(1976) described the microinjection of human and hamster spermatozoa into hamster oocytes. 
Despite the use of fine micropipettes, only a limited number of the injected oocytes survived this 
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technical procedure (Thadani, 1981). However, in 1988, Hosoi et al. obtained live offspring after 
the transfer of microinjected rabbit oocytes.  
It became apparent that the results of conventional IVF were much less efficient when the semen 
characteristics of the male partner were well below the reference values (Devroey and Van 
Steirteghem, 2004). By the end of the 1980‟s several procedures of ART were developed to 
overcome these problems. Since fertilization of normal animal gametes and live offspring after 
microinjection techniques were described, scientists experimentally applied microinjection 
techniques to human gametes. PZD (partial zona dissection) was one of the techniques developed 
in an attempt to improve fertilization and pregnancy rates with male factor infertility patients (Cohen 
et al., 1988). This technique allowed the spermatozoon to have direct access to the oocyte‟s 
oolemma by means of a small opening that was made in the zona pellucida (see Figure 1.1). The 
results obtained from PZD were generally inconsistent and disappointing. It was thought that the 
PZD process reduced the protection of the oocyte which the intact zona pellucida offered against 
waste substances and oxygen radicals produced by the non-motile and defective spermatozoa.  
Another micromanipulation technique called SUZI (subzonal insemination) was developed where a 
few motile spermatozoa were microinjected through the zona pellucida into the perivitelline space 
(Ng et al., 1988). However, the overall experience with PZD and SUZI was that the percentage 
normal fertilization as well as pregnancy rates was too low to consider it for routine clinical 
application. Although ICSI was first applied to human gametes in 1988, Palermo et al. (1992) was 
the first to publish human pregnancies and deliveries generated after ICSI. Since then the use of 
the ICSI procedure has resulted in fertilization and pregnancy rates comparable to those obtained 
in patients with normal semen parameters undergoing conventional IVF (Palermo et al., 1995a).  
ICSI quickly became the favoured technique for cases of male-factor infertility, as it was discovered 
that basic semen parameters (low sperm count or motility) had little impact on its success (Nagy et 
al., 1995). ICSI also enabled scientists to achieve high levels of fertilization in the presence of 
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multiple morphological and dysfunctional sperm defects. ICSI started to be used for cryopreserved-
thawed sperm as well as sperm extracted from the testis (Devroey and Van Steirteghem, 2004). 
Today, ICSI indications have expanded beyond just male-factor infertility and include multiple failed 
IVF cycles, mixed factor infertility, poor fertilization for unknown reasons, patients that require 
preimplantation genetic diagnosis (PGD) and patients using vitrified oocytes for a IVF cycle (Sauer 
and Chang, 2002; Palermo et al., 2009; De Mouzon et al., 2010). 
 
 
 
 
 
Figure 1.1 Illustration of the differences between PZD, SUZI and ICSI techniques. (Available at: 
http://www.sotiriskoukos.gr/content.php?content_id=54&lg=) 
 
 
1.2  Differences involved during natural and ICSI fertilization processes  
1.2.1  Natural fertilization process  
The fertilization processes involved during natural conception and IVF are complex and still 
researched today. In order for a morphologically normal and mature spermatozoon to fertilize a 
mature oocyte, the spermatozoon needs to undergo capacitation. This process refers to the ability 
of a spermatozoon to initiate the fertilization process including the physiological acrosome reaction. 
In the human, spermatozoa capacitate in vivo upon exposure to the female reproductive tract 
secretions, but capacitation of spermatozoa can be induced in vitro in the presence of various 
Partial zona dissection 
(PZD) 
Subzonal insemination  
(SUZI) 
Intracytoplasmic sperm 
injection (ICSI) 
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synthetic media during semen preparation techniques (Fenichel et al., 1995). Although the 
spermatozoon does not portray any visual signs of capacitation, it involves the post ejaculatory 
mobilization and/or removal of certain spermatozoon plasma membrane surface compounds, such 
as glycoproteins, decapacitation factor, acrosome-stabilizing factor and acrosin inhibitor. These 
changes in the distribution of intramembranous particles result in areas over the acrosome that 
become free of these particles during capacitation (Tesarik, 1984). Other intracellular changes 
during capacitation include increases in membrane fluidity, protein tyrosine phosphorylation, and 
cAMP (cyclic adenosine monophosphate) concentrations. It also includes decreases in 
cholesterol/phospholipid ratio of the plasma membrane and net surface charge, as well as changes 
in spermatozoon swimming patterns. These alterations to the membrane phospholipids initiate 
modest rises in intracellular Ca2+ and Na+ ions prior to the acrosome reaction.  
When a spermatozoon reaches the cumulus-oocyte complex (COC), it penetrates the cumulus 
mass, binds to and penetrates the zona pellucida (ZP) and fuses with the oocyte oolemma in order 
to fertilize the oocyte. The acrosome that caps the spermatozoon‟s head contains enzymes 
required for this penetration and fusion processes. Some of the enzymes include hyaluronidase, 
acrosin, proacrosin, phosphatase arylsulfatase, collagenase, phospholipase C and β-galactosidase 
(Dale, 1996). Hyaluronidase is required to digest the hyaluronic acid (HA) matrix that forms the 
cumulus cloud around the oocyte. In vitro, the hyaluronidase enzyme from spermatozoa is also 
released from the acrosomes of dying or dead spermatozoa that will cause the digestion of the 
whole cumulus mass around the oocyte.  
Before or during the cumulus penetration process, the spermatozoon becomes hyperactivated. The 
spermatozoon‟s tail movement frequency increases and its movement pattern changes from two-
dimensional to three-dimensional (Cleine, 1996). These changes in movement assist the 
spermatozoon to penetrate the cumulus. The HA present in the cumulus matrix has a vital function 
in selecting only mature sperm which ultimately binds and penetrates the ZP and fertilize the 
oocyte during in vivo or in vitro fertilization (Parmegiani et al., 2010b). 
Stellenbosch University  https://scholar.sun.ac.za
5 
 
The human ZP consists of three glycoproteins; ZP1, ZP2 and ZP3. These glycoproteins, together 
with protein-bound progesterone from the cumulus mass, form a complex in the outer layer of the 
ZP. Some have postulated a three stage model for sperm-zona pellucida interaction; the first 
comprises primary binding of acrosome-intact spermatozoa to the ZP, followed by secondary 
binding of the acrosome-reacted spermatozoa to the zona pellucida and finally penetration of the 
acrosome-reacted sperm through the zona pellucida into the perivitelline space (Saling et al., 1979; 
Swenson and Dunbar, 1982; Redgrove et al., 2012). Spermatozoa contains a large number of ZP 
receptor candidates that accounts for the sequence of both low and high affinity interactions 
(Thaler and Cardullo, 2002). When the spermatozoon reaches and attaches to the ZP, this protein 
complex of the ZP has an inducing effect on the acrosome reaction. For the spermatozoon to be 
able to attach, the acrosome should still be intact and the spermatozoon should have a normal 
morphology. A morphologically abnormal spermatozoon will not bind to the ZP due to its shape or 
a resulting defect in its receptor area. The morphologically normal spermatozoon‟s head binds 
loosely to the ZP and the acrosome reaction is initiated (Kopf et al., 1991).  
During the acrosome reaction the contents of the acrosome are released by exocytosis. A Ca2+ 
influx causes the spermatozoon head‟s lipid membrane to change and more receptors to be 
exposed. This will cause the spermatozoon to bind more tightly to the ZP proteins (Cleine, 1996). 
The Ca2+ influx also induce the fusion between the phospholipids of the outer acrosomal 
membrane and the overlying plasma membrane. These multiple fusion areas form pores through 
which the hydrolytic enzymes from the acrosome are released. These enzymes (mostly acrosin) 
digest the ZP, allowing the spermatozoon to approach the oocyte for fertilization (Takano et al., 
1993). Finally the acrosome cap falls away and only the equatorial segment remains. Only 
spermatozoa that are able to undergo the acrosome reaction when bound to the ZP can penetrate 
the zona by enzyme digestion from the acrosome and vigorous hyperactivated motility (Cleine, 
1996).  
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After the acrosome-reacted sperm reaches the perivitelline space (PVS), it fuses with the oocyte 
oolemma. Spermatozoa that contain the appropriate oolemma fusion receptors will be anchored by 
firm binding between the inner acrosomal membrane and the microvilli. Here too it is important for 
the spermatozoon to have a normal shaped head, so that the receptors can make good contact 
with the oocyte. The binding between the oocyte oolemma and the equatorial segment of the 
spermatozoon‟s head begins, after which fusion starts (Cleine, 1996; Wassarman et al., 2005).  
Once fusion occurs, the spermatozoon is incorporated into the ooplasm and the acrosome 
membrane and tail are disrupted from the zygote. Oocyte-activating proteins, such as 
phospholipase C zeta (PLCζ), are released into the oocyte‟s cytosol by the spermatozoon which 
triggers calcium oscillations (Saunders et al., 2002). The intracellular calcium rise will start within a 
few minutes of spermatozoa fusion and is largely due to the release of calcium from intracellular 
stores within the endoplasmic reticulum (Wakai and Fissore, 2013). This increase in oocyte 
cytoplasmic Ca2+ levels activates the oocyte. The oocyte extrudes cortical granules into the PVS 
(Sathananthan and Trounson, 1982) to prevent any secondary spermatozoa from transit further in 
the ZP and into the PVS. This process, known as the cortical reaction, prevents polyspermy as well 
as protects and supports the embryo.  
After the spermatozoon and oocyte fuses, the envelope around the spermatozoon nucleus 
disintegrates. The nucleus decondenses to a haploid set of chromosomes and a nuclear 
membrane around the chromosomes developes. This forms the male pronucleus. The oocyte 
extrudes the second polar body, also undergo chromatin decondensation and form the female 
pronucleus (Sathananthan et al., 1993). Both pronuclei migrate to the centre if the oocyte until 
syngamy takes place. The microtubules of the spermatozoon aster play a role in this migration 
process. This organelle grows out into a star shape from the centrosome from the mid-piece of the 
spermatozoon. The centrosome and the male pronucleus are driven by the growing sperm aster 
from the cell cortex towards the centre of the oocyte where syngamy will take place (Barroso and 
Oehninger, 2007).  
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1.2.2 Fertilization process during ICSI 
With ICSI, a single spermatozoon is injected directly into a denuded oocyte‟s cytoplasm. This 
method bypasses the penetration through the cumulus mass, binding to the ZP, penetration 
through the ZP and fusion with the oocyte‟s oolemma. By bypassing these spermatozoon-oocyte 
interaction processes, spermatozoa are not naturally selected before spermatozoon-oocyte fusion 
(Sathananthan et al., 1989). Motile spermatozoa with normal morphology have an increased 
chance of fertilization and embryo development (Sathananthan and Trounson, 1999) and one of 
the drawbacks in ICSI is the inability to select a morphologically normal, viable spermatozoon with 
absolute certainty.  
Since ICSI bypasses so many penetration and binding processes through the cumulus mass, ZP 
and oolemma, the acrosome may be seen as unnecessary. However, Katayama et al. (2002) 
found that the delay of sperm chromatin decondensation is associated with that of acrosome 
disassembly. They also found that acrosomes appear to disintegrate in the oocyte ooplasm 
whether or not the acrosome reaction has taken place. As previously discussed, the acrosome 
reaction occurs spontaneously during incubation in a defined medium and is also time dependent 
(Schill et al., 1988). Based on these observations, Mansour et al. (2008) examined the impact of 
spermatozoa preincubation time and spontaneous acrosome reaction in ICSI and found that the 
optimum incubation time of spermatozoa before ICSI was three hours, which resulted in a higher 
fertilization rate. However, the only statistically significant difference between the different 
incubation period groups was the rate of acrosomal reacted spermatozoa. This rate was the 
highest after five hours of incubation and lowest after one hour of incubation. They stated that it 
seems to be physiologically correct to use acrosome-reacted spermatozoa for ICSI to avoid 
irregular sperm chromatin decondensation that adversely affect fertilization.  
The same activation processes of the oocyte (during IVF or natural conception) occur when 
spermatozoa are microinjected into oocytes during ICSI (Homa and Swann, 1994; Tesarik et al., 
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1994). During IVF the initial calcium increase starts within a few minutes of spermatozoa fusion, 
whereas following ICSI this trigger is provoked immediately during injection by the artificial calcium 
influx from the surrounding injection medium (Tesarik et al., 2000).  
Since ICSI is an invasive fertilization technique that bypasses multiple steps of the natural sperm 
selection and fertilization process by introducing spermatozoa into the ooplasm, it is important to 
consider the immediate safety of ICSI as well as any possible long term implications. According to 
Wong and Ledger (2013), the potential concerns regarding ICSI offspring relate to four general 
areas; transmission of genetic anomalies, imprinting disorders, congenital malformations and 
developmental abnormalities. In 2013, Davies et al. presented data from the largest registry to 
date, comparing 6163 births from ART. Their finding showed that IVF and ICSI is associated with a 
significant increase in risk of birth defects, but that this risk persists only after the use of ICSI, not 
IVF, after adjustment for parental and other factors. This finding can be explained by one of two 
ways; either the ICSI procedure itself is dangerous by causing structural damage during the 
procedure or there may be some underlying factors associated with the couples chosen for ICSI.  
Wong and Ledger (2013) however reasoned that there are several explanations for why the results 
of this study recorded such high risks of birth defects in comparison to similar studies in the past. 
The authors did not separate twin from singleton pregnancies, single from double embryo transfers 
and included cerebral palsy as a birth defect. A meta-analysis done in 2012 by Wen et al. is only 
one of the many studies that differ from the findings of Davies. In this analysis the outcome of 46 
studies covering 125 000 IVF and IVF/ICSI babies demonstrated a small increased risk of 
congenital abnormalities with IVF and ICSI babies compared to natural conception, but no 
difference in the risk between IVF and ICSI conceptions.  
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1.3  Different factors that can influence ICSI outcome  
The success rate of ICSI is thought to be influenced by a number of factors, some which include 
oocyte quality (Loutradis et al., 1999), sperm quality (Nagy et al., 1998), ICSI technique as well as 
the injection needles being used (Svalander et al., 1995).  
 
1.3.1  Sperm count 
Nagy et al. (1998) found that only semen with an extremely low sperm count (no spermatozoa 
seen in initial semen sample; cryptozoospermia) showed a significant lower fertilization rate during 
ICSI than semen with a sperm count of >5 million per milliliter. Strassburger et al. (2000) also 
reported a significant decrease in fertilization and pregnancy rate in cryptozoospermic ICSI cycles 
when compared to the control group (sperm concentration of >1x105 and <10x106/ml). 
 
1.3.2  Sperm motility and viability  
During natural conception or IVF, spermatozoa need to be motile and be hyperactive to penetrate 
the oocyte‟s cumulus as well as the zona pellucida. Men without any motile spermatozoa are 
infertile without ICSI (Aitken et al., 1983). Motility might be a critical factor when selecting 
spermatozoa for ICSI, considering clinical results by Nagy et al. (1995). Shen et al. (2003) also 
found that one of the important laboratory variables that affected the fertilization rate during ICSI 
was sperm motility. However, sometimes spermatozoa have to be selected for ICSI from a 
complete immotile sperm population (absolute asthenozoospermia). For this particular group of 
patients, non-harmful methods to identify live/viable spermatozoa suitable for ICSI were pursued, 
since sperm vitality is a prerequisite for successful ICSI (Nagy et al., 1995). These include hypo-
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osmotic swelling test, mechanical touch technique, exposure to Pentoxifylline, laser-assisted sperm 
selection and birefringence-polarization microscopy (Ortega et al., 2011).  
The sperm centrosomal material contains centrioles and centrosomal components onto which 
oocyte centrosomal proteins assemble after sperm incorporation to form the sperm aster that is 
essential for uniting sperm and oocyte pronuclei (Schatten and Sun, 2009). This organelle 
contributes to the assembly of microtubule within the penetrated oocyte, which contributes to the 
formation of the first mitotic spindles during the initial fertilization phase and initiates embryonic cell 
division. Sathananthan et al. (1996a; 1997) reported that fertilization with spermatozoa with 
abnormal or damaged centrioles could lead to embryos with cleavage arrest or irregular cleavage 
patterns, since embryos‟ centriolar apparatus and mitotic potential are paternally derived. 
Unfortunately these defects are not visible in spermatozoa, but it is believed that immotile 
spermatozoa as well as poorly motile spermatozoa with no forward progression are more likely to 
have these defective centrosomes (Sathananthan, 1996b).  
Since it is recognized that the microscopic method for assessing motility is subjective to large 
errors, many researchers use commercial computer systems that provides objective assessment of 
sperm motility and kinetic characteristics (time-varying geometric aspects of motion; Drobnis et al., 
1988; Mortimer, 2000). With a computer assisted semen analysis (CASA) system, spermatozoa 
are recognized based on the size and brightness of the head. The computer will take consecutive 
video recordings and evaluate spermatozoa‟s difference in position in several consecutive frames.  
Kinetics of sperm motility such as average sperm velocities, curvilinear velocity speed (VCL), 
straight line velocity (VSL), average path velocity (VAP), amplitude of lateral head displacement 
(ALH), beat cross frequency (BCF), percentage straightness (STR) and percentage linearity (LIN) 
are some of the characteristics CASA systems can evaluate (Addendum I). Some of these 
characteristics have been significantly correlated with fertilization rates in vitro(Mortimer, 1989), but 
there are no consistent findings and it is still not clear which characteristics of sperm movement are 
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useful for predicting fertility (Hirano et al., 2001). However, various studies have used some of 
these motion parameters to analyse spermatozoon hyperactivation. Mortimer et al. (1990) defined 
hyperactivated spermatozoa by the following criteria: ALH ≥5.0µm, LIN ≤60% and VCL ≥100µm/s. 
 
1.3.3  Sperm morphology 
The importance of sperm morphology in IVF was first described by Kruger et al. (1986) and today it 
is seen as one of the most important semen parameters of male infertility assessment that 
correlates with natural in vivo fertilization, in vitro fertilization as well as pregnancy outcome (Kruger 
et al., 1996; Coetzee et al., 1998; Avendaño et al., 2009). Menkveld and colleagues developed the 
Tygerberg Strict Criteria morphological classification of human spermatozoa (Kruger et al., 1986; 
Menkveld et al., 1990; Kruger et al., 1996) which is still internationally used today. Three prognostic 
categories with the Strict Criteria was described by Kruger et al. (1996) and include the poor-
prognosis or p-pattern group (1-4% morphologically normal spermatozoa), good-prognosis or g-
pattern group (5-14% morphologically normal spermatozoa) and normal-prognosis or n-pattern 
group (>14% morphologically normal spermatozoa).  
Previous studies reported positive predictive values for IVF success rates using the 5% and 15% 
sperm morphology thresholds as described by the Tygerberg Strict Criteria. They observed a 
significant decrease in pregnancy rates in the p-pattern morphology group (Coetzee et al., 1998; 
Van der Merwe et al., 2005). On the other hand, Nagy et al. (1995; 1998) showed that the outcome 
of ICSI is not related to strict morphology of the sperm used for microinjection. They reported that 
the fertilization rate obtained with semen samples in the p-pattern morphology group do not differ 
from samples with better overall sperm morphology. This observation can be explained by the fact 
that the embryologist selects a motile, morphologically normal-looking spermatozoon for injection 
within the limits of the microscope used for micromanipulation (x400 magnification). Mansour et 
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al.(1995) stated that as long as morphologically well-shaped viable spermatozoa are used for 
injection, fertilization and pregnancy rates after ICSI are not affected.  
However, the overall appearance of a sperm sample does not always reflect the quality of the 
spermatozoon injected. De Vos et al. (2003) evaluated the influence of individual spermatozoon 
morphology on the outcome of ICSI in terms of fertilization, embryo development on day two and 
implantation rate after embryo transfer. They found that individual sperm morphology assessed at 
the moment of ICSI correlated well with fertilization outcome, but did not affect embryo 
development up until day two cleavage stage. However, previous studies found that male factor 
infertility affect blastocyst formation and quality and decrease the ability of ICSI-derived embryos to 
develop to blastocyst compared with IVF-derived embryos (Jones et al., 1998; Shoukir et al., 1998; 
Loutradi et al., 2006). Furthermore, De Vos et al.(2003) also found that the implantation rate was 
significantly lower when only embryos resulting from injection of abnormal spermatozoa were 
available. They speculated that when the morphology of ICSI semen samples are evaluated, many 
spermatozoa are classified as abnormal on the basis of morphologic details that might not interfere 
with their fertilizing capacity, since they will be directly introduced into the oocyte and bypass the 
zona pellucida and oolemma barriers.  
 
1.3.4  Sperm DNA 
Sperm chromatin abnormalities as a cause of male infertility have been studied extensively in the 
past two decades. Evidence indicates that a negative correlation exists between disturbances in 
the organization of the genomic material in sperm nuclei and the fertility potential of spermatozoa, 
whether in vivo or in vitro. This emphasizes that stable DNA is one of the criteria needed for a 
spermatozoon to be considered as fertile (Amann et al., 1989; Sun et al., 1997; Spano et al., 
2000).   
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A poor quality sperm chromatin structure may be an indication of male subfertility, regardless of the 
number, motility or morphology of spermatozoa. Various studies reported that sperm DNA damage 
is useful as a predictor of treatment success, as suggested by its association at numerous points in 
the reproductive process, including impaired fertilization, disrupted pre-implantation embryo 
development, miscarriage and birth defects in the offspring (Simon et al., 2011; Zini, 2011; Bungum 
et al., 2012). Thus, sperm chromatin structure evaluation can provide good diagnostic and 
prognostic capabilities and may be considered as a reliable predictor of a couple‟s ability to 
conceive (Evenson et al., 1999; Aitken, 1999).  
 
1.3.4.1  Human sperm chromatin structure 
The function of a spermatozoon is to successfully transport and deliver the paternal chromosomes 
to the oocyte during reproduction (Sousa et al., 2009). The spermatozoon contains a haploid set of 
DNA that is situated in the nucleus in the post acrosomal part of the sperm head. The DNA 
molecules consist of many nucleotides that are involved in carrying the paternal genetic 
information, which includes the sex-determining X or Y chromosome (Hoogendijk et al., 2007).  
The status of a spermatozoon‟s nucleus depends on two events during spermiogenesis; the final 
nuclear shape acquisition and the replacement of histones with protamines (P1 and P2) for the 
formation of compact and stable chromatin. This organized, condensed and compacted chromatin 
packaging almost occupies the entire volume of the small sperm nucleus and ensures that the 
DNA transferred to the oocyte is delivered in a physical and chemical form that allows the 
developing embryo to access the genetic information (Poccia, 1986). The condensation of sperm 
DNA is also important for the repression of gene expression during spermiogenesis and to protect 
the paternal genetic message, during transport through the male and female reproductive tracts, 
making it inaccessible to nucleases or mutagens (Oliva, 2006).  
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The organization of the chromatin for packaging in the spermatozoon takes place at four different 
levels: 1) chromosomal anchoring where the DNA attaches to the nuclear annulus; 2) DNA loop 
domain formation as the DNA attaches to the newly added nuclear matrix; 3) histone replacement 
with protamines which condense the DNA structure and 4) chromosomal positioning (Ward and 
Coffey, 1991).  
 
1.3.4.2 Origin of sperm DNA damage 
Sperm DNA abnormalities can be induced during any of its developmental, storage or transport 
stages (Fernández et al., 2008; Sakkas and Alvarez, 2010) and can be triggered by internal or 
external factors. Abnormal genomic material (internal factor) may cause abnormalities such as 
DNA compaction, nuclear maturity defects, DNA strand breaks, DNA integrity anomalies or sperm 
chromosomal aneuploidies (Shafik et al., 2006). In 2009, Varghese et al. concluded that the 
amount of spermatozoa with damaged DNA is predominantly higher in the ejaculate of men with 
poor quality semen. Their study supported the results from Shafik et al. (2006) who stated that 
anomalies within the sperm DNA may be associated with abnormal semen parameters.  
The aetiology of sperm DNA damage is probably multi-factorial, but the three main theories by 
which DNA damage arise in human spermatozoa have been proposed as defective sperm 
chromatin packaging, oxidative stress and abortive apoptosis (Schulte et al., 2010).  
 
a) Incomplete chromatin packaging 
There are a few events associated with spermiogenesis that can cause genetic instability in mature 
spermatozoa (Leduc et al., 2008). Spermatozoa with an altered protamine 1 and 2 (P1/P2) ratio 
are normally more susceptible to stressors and have been correlated with sperm DNA 
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fragmentation (Garcia-Peiró et al., 2011). However, the cause of the deregulation of protamine 
expression in male infertility remains unclear.  
Histone-protamine replacement, epididymal maturation and chromatin stability during ejaculation 
are events where sperm chromatin abnormalities can occur. Chromatin protein modification or 
absence can lead to abnormal chromatin packaging and influence the quality of spermatozoa and 
fertilization potential (Kazerooni et al., 2009).  
When spermatozoa with improper chromatin packaging are exposed to stressors such as extreme 
temperatures or frequent pH changes, the DNA can fragment and lead to single strand chromatin 
(Varghese et al., 2009).  
 
b) Oxidative stress 
Oxidative stress seems to have a critical influence on male reproduction. In fact, Aitken and De 
Iuliis (2010) reported that the most common cause of DNA fragmentation in spermatozoa is 
oxidative stress. It is caused by excessive reactive oxygen species (ROS) which include highly 
oxidative radicals, such as hydroxyl radicals (OHˉ), and nonradical species, such as hydrogen 
peroxide (H2O2; Aitken and Bennetts, 2007). Both ROS species are normal by-products of 
metabolism (Valko et al., 2007) and are required in low concentrations for many cellular processes. 
In spermatozoa, ROS plays an important role in a number of essential functions, i.e. chromatin 
compaction in maturing spermatozoa during epididymal transit (Wright et al., 2014), capacitation 
(Doshi et al., 2012), hyperactivation (Nassar et al., 1999), binding of the spermatozoon to the zona 
pellucida (Liu et al., 2006) and acrosome reaction (Dona et al., 2011). This explains why 
spermatozoa produce ROS themselves. These ROS are relatively harmless to spermatozoa under 
normal concentrations and conditions where antioxidant mechanisms help maintain the balance 
required for ROS-related functions (Sharma and Agarwal, 1996).  
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Cellular components such as proteins, lipids, RNA (ribonucleic acid) and DNA molecules are 
chemically modified by excess ROS and causes normal cell function impairment. Spermatozoa are 
particularly vulnerable to ROS for three reasons: (i) their plasma membrane is largely composed of 
polyunsaturated fatty acids that renders it highly susceptible to oxidative and other chemical 
modifications; (ii) they have inherent deficiencies in intracellular antioxidant enzyme protection; and 
(iii) they have a limited capacity for DNA damage detection and repair, unlike most cell types 
(Lewis et al., 2013).  
ROS is produced by morphologically abnormal, immature or dead spermatozoa as well as seminal 
leukocytes and can damage sperm DNA by inducing double- and single-stranded DNA breaks 
(Thomson et al., 2011) that has been linked to male infertility (Laberge and Boissonneault, 2004). 
Clinical studies done by Moskovtsev et al. (2007) demonstrated a weak correlation between 
leukocyte concentration and sperm DNA damage, suggesting that leukocyte-derived ROS are not 
as important as those derived from spermatozoa. ROS can also cause DNA damage such as 
chromatin cross-linking, chromosome deletion, mutations and base oxidation (Agarwal et al., 
2003).  
Spermatozoa are especially vulnerable for damage caused by oxidative stress, since they have no 
defence mechanism, apart from the characteristic tight packaging of the DNA and anti-oxidants 
present in the seminal plasma. DNA repair is also limited in spermatozoa and only occurs during 
specific stages of spermiogenesis. Spermatozoa are exposed to oxidative damage in the 
epididymis and during the transport in seminal fluid. However, its repair mechanism is no longer 
activated during nuclear condensation in the epididymis (Leduc et al., 2008). The next opportunity 
for DNA damage repair is by the oocyte. Not all DNA damage may be repairable by the oocyte and 
can have a significant impact on fertilization, embryo quality and clinical pregnancy outcome after 
IVF and ICSI (Lewis and Simon, 2010; Gonzalez-Marin et al., 2012).  
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c) Abortive apoptotic DNA degradation 
Apoptosis is more commonly described as programmed cell death and has been associated with 
sperm chromatin condensation and DNA fragmentation (Jégou et al., 2002). This event is induced 
by specialized Sertoli cells, within the seminiferous tubules of the testes, which will prevent the 
overproduction of germ cells and selectively destroy injured germ cells. These germ cells are 
assigned with apoptotic markers and are supposed to be phagocytised and be removed by the 
Sertoli cells (Sakkas and Alvarez, 2010). However, some damaged germ cells may escape the 
apoptotic pathway, known as abortive apoptosis, enter spermiogenesis and end up in the ejaculate 
(Sakkas et al., 2002).  
Apoptotic DNA degradation in spermatozoa may be caused during internal (in vivo) or external (in 
vitro) conditions. Some of these conditions include hormonal depletion, irradiation, toxic agents, 
chemicals, heat exposure, the presence of leukocytes, the production of free radicals during 
migration, inflammation, infection, ROS and antioxidant depletion (Barroso and Oehninger, 2007; 
Bronet et al., 2012).  
 
d) External factors 
Apart from the above mentioned three main theories that can cause DNA damage in human 
spermatozoa, external factors may also affect sperm DNA integrity. These include lifestyle factors, 
such as diet (Leduc et al., 2008), alcohol (Varshini et al., 2012) and caffeine consumption (Schmid 
et al., 2006), cigarette smoking (Valavanidis et al., 2009), antibiotics (Wright et al., 2014), air 
pollution (Rubes et al., 2005) and hyperthermia that can lead to excessive ROS production 
(Mieusset et al., 1987; Ollero et al., 2001). Other conditions that are increasingly linked to sperm 
DNA abnormalities include obesity (Dupont et al., 2013), cancer (Shafik et al., 2006), genital tract 
Stellenbosch University  https://scholar.sun.ac.za
18 
 
inflammation, semen infections, hormonal disorders (American Society of Reproductive Medicine, 
2008; Sakkas and Alvarez, 2010) and ageing (Schmid et al., 2006).  
 
1.3.4.3 Evaluation of sperm nuclear DNA damage 
 
There are different assays available to evaluate sperm DNA abnormalities, immaturity or damage. 
Some of these assays include:  
a) simple staining techniques such as the acidic aniline blue (AB) and toluidine blue (TB) 
stains,  
b) fluorescent staining techniques such as the sperm chromatin dispersion (SCD) test, 
chromomycin A3 (CMA3), DNA breakage detection-fluorescent in situ hybridization assay 
(DBD-FISH), in situ nick translation (ISNT), flow cytometric-based sperm chromatin 
structure assay (SCSA), acridine orange test (AOT) together with terminal deoxynucleotidyl 
transferase-mediated fluorescein-deoxyuridine triphosphate nick-end labelling (TUNEL) 
assay, and lastly high-performance liquid chromatography (HPLC),  
c) an electrophoretic technique - the single-cell gel electrophoresis (COMET) assay (Henkel, 
2007a, Muratori et al., 2010).  
Despite extensive research for the successful implementation of sperm DNA tests into routine 
practice, a universal agreement on the ultimate technique for the accurate evaluation of human 
sperm DNA integrity has not yet been reached (Cohen et al., 2004; Shafik et al., 2006; Muratori et 
al., 2010).However, of all the methods currently available, the COMET assay is considered the 
most sensitive (Villani et al., 2010). Not only does it detect single- and double-strand breaks as well 
as abasic sites (DNA sites with neither a purine nor a pyrimidine base), but it is the only test that 
quantifies DNA fragmentation in an individual spermatozoon.  
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Simon et al. (2014) reported that the development of novel diagnostic approaches that will allow 
non-invasive evaluation of individual sperm with minimal DNA damage could be a potentially 
valuable tool to improve ART success.  
 
a)  Chromomycin A3 assay  
CMA3 is a guanine-cytosine-specific fluorochrome that competes with protamines for binding to the 
minor groove of the DNA helix. CMA3 fluorescence has been interpreted as an indirect 
demonstration of decreased presence of protamine leading to poor protamination (Lolis et al., 
1996). It reveals chromatin that is poorly packaged in human spermatozoa by detecting protamine-
deficiency in loosely packed chromatin. CMA3 stains the post acrosomal part of the sperm head. 
Spermatozoa with immature chromatin packaging will be fluorescent yellow after staining. A low 
protamination state will therefore be indicated by high levels of CMA3 fluorescence. Dull or no 
fluorescent stain indicates mature chromatin packaging. (Esterhuizen et al., 2000; Agarwal and 
Said, 2004).  
 
As a discriminator of IVF success (>50% oocytes fertilized), CMA3 staining has a sensitivity of 73% 
and specificity of 75%. Therefore, it can distinguish between IVF success and failure (Esterhuizen 
et al., 2000). In 1996, Sakkas et al. reported that spermatozoa from patients with high CMA3 
fluorescence and a higher level of endogenous DNA nicks are not limited in their ability to achieve 
fertilization using ICSI when compared to patients exhibiting low levels of these two parameters 
However, in 1998 Sakkas et al. concluded that patients with poor chromatin packaging (>30% 
CMA3 fluorescence), had more than double the number of unfertilized oocytes during ICSI. They 
also concluded that DNA fragmentation may be linked to an increase in early embryo death. In 
2009, Kazerooni et al. also showed that the number of CMA3 positive spermatozoa is significantly 
higher in patients with spontaneous recurrent abortions.  
 
Stellenbosch University  https://scholar.sun.ac.za
20 
 
The CMA3 assay is reliable as it strongly correlates with other assays used to evaluate sperm 
chromatin (Manicardi et al., 1995). It is however important to remember that this assay is limited by 
observer subjectivity.  
 
b)  Terminal deoxynucleotidyl transferase dUTP nick-end labelling (TUNEL) assay 
The TUNEL assay was first developed by Ausubel et al. in 1992 and Gorczyca et al. (1993b) was 
the first to apply this method to spermatozoa. This assay determines the existing DNA damage of 
spermatozoa and is based on the ligation of labelled dUTP-nucleotides to the 3‟-OH phosphate 
ends of single- as well as double-stranded DNA breaks (Nakamura et al., 1995). This reaction is 
catalysed by the template-independent enzyme, terminal deoxynucleotidyl transferase (TdT). By 
using labelled dUTP-nucleotides, DNA fragmentation in spermatozoa can be identified by using 
bright field microscopy, fluorescent microscopy as well as flow cytometry (Gorczyca et al., 1993a; 
Muratori et al., 2010). Spermatozoa with normal DNA have only background staining, while those 
with fragmented DNA (multiple chromatin 3‟ –OH ends) stain brightly (Gorczyca et al., 1993a).  
The TUNEL assay provides useful information in many cases of male infertility. Researchers found 
a negative correlation between the DNA fragmented sperm percentage and the motility, 
morphology and concentration in the ejaculate (Lopes et al., 1998; Henkel, 2007b; Aitken and De 
Iuliis, 2007). This assay appears to be potentially useful as a predictor for Intra-uterine 
insemination (IUI) pregnancy rate, IVF embryo cleavage rate and ICSI fertilization rate. It also 
provides an explanation for recurrent pregnancy loss (Sun et al., 1997; Duran et al., 2002; Carrell 
et al., 2003; Muratori et al., 2003; Benchaib et al., 2003). Avendaño et al. (2009) was the first to 
simultaneously examine individual spermatozoa for normal morphology and DNA fragmentation 
and demonstrated that infertile men can present DNA fragmentation in the morphologically normal 
sperm population assessed by strict criteria. Furthermore, the evaluation of DNA integrity in 
morphologically normal spermatozoa after sperm selection was proposed to be a better approach 
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to evaluate the impact of sperm DNA fragmentation on ICSI outcome than the assessment of the 
total sperm population (Avendaño and Oehninger, 2011).  
 
Although the reliable thresholds for TUNEL require further conformation, a working threshold of 15-
20% is considered high and correlates with reduced fertility potential (Sharma et al., 2010). 
However, the threshold value commonly used is that from a study by Evenson et al. (1999) where 
they concluded that >30% DNA fragmentation was a threshold not considered compatible with 
fertility. Although the flow cytometric method is thought to be generally more accurate and reliable, 
it is more expensive and complex. This method may also detect DNA of cells other than 
spermatozoa. The epi-fluorescent TUNEL assay has demonstrated good quality control 
parameters with an intra-observer variability of less than 8% and an inter-observer variability of 
less than 7% (Barroso et al., 2000). When using this method, DNA fragmentation of other cells will 
not be included in your analysis, as one will only count spermatozoa.  
 
1.3.4.4 The role of sperm DNA in fertilization and ART outcomes 
 
a) Diagnosis of male infertility 
There is a consensus based on numerous publications that male partners in infertile couples have 
a higher level of sperm DNA fragmentation compared with those in the general population and 
proven fertile males (Lewis et al., 2013). Studies suggest a negative impact on both natural 
(Evenson et al., 1999; Spano et al., 2000) and ART conception (Larson et al., 2000). A significant 
DNA fragmentation level can be present in normozoospermic subfertile men, but it also coexists 
with reduced sperm count, increased abnormal morphology (Virro et al., 2004; Chi et al., 2011), 
and reduced motility (Lin et al., 2008). However, like most scientific research, results are 
controversial. A recent publication by the Practice Committee of the American Society for 
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Reproductive Medicine (2013) reported that recent methods for assessing sperm DNA integrity do 
not reliably predict treatment outcomes and cannot be recommended routinely for clinical use.  
Excessive ROS does not only damage sperm nuclear DNA, but can also damage mitochondrial 
DNA. Since male mitochondrial DNA is degraded by the oocyte, leaving only maternal inheritance 
of mitochondrial DNA, these sperm mitochondrial DNA mutations do not impact the health of the 
offspring (Sutovsky et al., 2004). However, it can limit ATP (adenosine triphosphate) production 
and energy provision for motility in spermatozoa, reducing fertility (Shamsi et al., 2008a).  
Even if a spermatozoon appears morphologically normal at high-power magnification, fertilization 
of a mature oocyte is still not guaranteed. This can be explained in that the fertilization potential of 
human spermatozoa also depends on its chromatin condensation ando DNA integrity. Sperm 
chromatin condensation does not play a direct role in the shaping of the sperm head. However, 
during the binding of protamine to DNA the DNA molecules are enabled to be condensed resulting 
in a more hydrodynamic sperm head and thus contribute indirectly to the shape of the head. It has 
been reported that sperm containing poor chromatin packaging frequently have enlarged or 
abnormal head shapes (Balhorn, 2007). Furthermore, associations between sperm chromosomal 
abnormalities and sperm morphology and head defects (amorphous, elongated or round heads 
and the presence of large nuclear vacuoles) have been reported (Chemes et al., 2007; Cassuto et 
al., 2009; Varghese et al., 2009). Cohen-Bacrie et al. (2009) also reported a positive correlation 
between sperm DNA fragmentation and sperm morphological abnormalities that included broken 
necks, abnormal necks and curled tails. Studies that were conducted to test the relationship 
between sperm morphology and IVF rates showed a positive correlation for normal morphology 
and IVF rates. A highly negative correlation was shown between percentage normal sperm 
morphology and poor chromatin packaging (Esterhuizen et al., 2000). However, some studies have 
reported that spermatozoa with normal morphology could have chromosomal aberrations and that 
sperm dimensions or shape are not reliable attributes in selection of haploid sperm for ICSI 
(Burrello et al., 2004; Celik-Ozenci et al., 2004).  
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b) Assisted reproductive technology (ART)  
The selection of spermatozoa with abnormal DNA during ART procedures may influence the 
genetic quality of the embryo (Sakkas and Alvarez, 2010). This can lead to impaired implantation 
and poor embryogenesis (Shafik et al., 2006; Lazaros et al., 2011) that may have an impact on a 
couple‟s fertility potential and ART outcome (Sakkas et al., 1995; Shafik et al., 2006). Abnormal 
DNA has also been associated with high abortion incidences and disease in offspring (Lewis and 
Agbaje, 2008; Thomson et al., 2011). However, despite a significant amount of research 
associating sperm DNA damage with ART outcomes, the results remain controversial. These 
discrepancies suggest that the type of assay used to measure sperm DNA damage may influence 
the detection of associations with ART outcomes (Simon et al., 2014).  
According to the sperm chromatin structure assay (SCSA) threshold for fertility, a DNA 
fragmentation index (DFI) higher than 30% is statistically significant and is associated with poor 
fertilization rates in IUI, IVF and ICSI (Lopes et al., 1998; Fernández et al., 2003; Apedaile et al., 
2004; Fernández et al., 2005; Oleszczuk et al., 2011). The DFI describes the number of 
spermatozoa with fragmented DNA expressed as a percentage of the total sample. As early as 
1998 Sakkas et al. found that patients with poor chromatin packaging (>30% CMA3 fluorescence), 
had more than double the number of unfertilized oocytes after ICSI. They also concluded that DNA 
fragmentation may be linked to an increase in early embryo death. However, a meta-analysis done 
by Li et al. (2006) found no relationship between sperm DNA damage (using SCSA or TUNEL) and 
fertilization rates during IVF or ICSI. According to them this finding was not completely unexpected 
since the paternal genome is not expressed until the four- to eight-cell stage, thus fertilization may 
not be dependent on sperm DNA integrity. This late paternal effect has been mainly attributed to 
abnormalities in the organization of the sperm chromatin, such as reduced chromatin 
condensation, chromosome anomalies and increased DNA strand breaks or fragmentation (Tesarik 
et al., 2004; Wiener-Megnazi et al., 2012).  
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Studies have also shown that sperm DNA abnormalities may influence the embryo at various 
levels, including nuclear, cytoskeletal and at the organelle level, thus influencing the embryo‟s 
morphology and development (Thomson et al., 2011). The DNA integrity of human spermatozoa 
contributes significantly to embryonic growth and fetal health (Kumar et al., 2012). Some scientists 
believe that embryonic failure may occur as a result of DNA repair failure in the oocyte. It has been 
stated that when spermatozoaonly show slight DNA damage, the oocyte might have the capability 
to repair this nuclear damage (Meseguer et al., 2011). The extend of the repair will however 
depend on the quality of the oocyte as well as the severity of the sperm DNA damage. If the DNA 
damage is too severe, the human embryo‟s natural protection mechanisms and pathways will 
prevent further embryonic development (Sakkas and Alvarez, 2010). However, some lesions may 
be repaired incorrectly or remain impaired. This can lead to fertilization failure, poor embryo quality, 
non-viable embryos or pregnancy loss (Shafik et al., 2006; Avendaño et al., 2010; Balasuriya et al., 
2011).  
There is controversy as to the influence of sperm DNA damage on pregnancy rates with IVF and 
ICSI. Various studies reported a significant reduction of pregnancy rates following IVF or ICSI for 
patients with increased levels of sperm DNA damage (Henkel et al., 2003; Henkel et al., 2004; 
Virro et al., 2004; Frydman et al., 2008), while other contradicting studies reported no significant 
differences in pregnancy rates after IVF or ICSI between patients with high or low levels of sperm 
DNA damage (Huang et al., 2005; Zini et al., 2005; Benchaib et al., 2007). A meta-analysis by Zini 
and Sigma (2009) who analysed nine IVF and eleven ICSI studies showed a modest increased 
pregnancy chance after IVF in cases when the proportion of DNA damaged spermatozoa was 
below the threshold values for SCSA or TUNEL. Lewis et al. (2013) reported that sperm DNA 
damage has not been found to be predictive for ICSI treatment (Zini, 2011), except for one study 
(Bungum et al., 2007) who reported no significant difference in IVF and ICSI pregnancy outcomes 
between low and high DFI groups. When there were high levels of sperm DNA damage (DFI 
>30%), they reported pregnancy rates with ICSI were significantly higher than IVF. However, this 
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was not a randomised control study. Therefore, the impact of factors contributing to the choice of 
treatment cannot be excluded. 
Lewis et al. (2013) reported four hypotheses that may explain the finding that poor sperm DNA 
does not appear to impact ICSI outcomes adversely. Firstly, in ICSI treatment cycles, contrary to 
women in IVF cycles where the fertility problem often resides with the female partner, up to 30% of 
women with subfertile partners have no detectable fertility problems. Their oocytes may have more 
capacity to repair DNA damage even if the injected spermatozoon is of poor quality. Secondly, 
during ICSI, spermatozoa are injected into the optimal environment of the oocyte‟s ooplasm within 
a few hours after ejaculation. This may protect the spermatozoon from laboratory-induced damage, 
since it has been found that even the birthweight of IVF babies can be markedly influenced by 
minor differences in culture conditions (Dumoulin et al., 2010). Thirdly, since it has been reported 
that spermatozoa from up to 40% of infertile men have high levels of ROS (Aitken et al., 2012), 
oocytes can be exposed to ROS released from the 0.5 million spermatozoa overnight during IVF. 
This may impair the oocyte‟s functional ability, including its capacity to repair sperm DNA 
fragmentation post fertilization. Finally, it has been reported that embryos with high sperm DNA 
damage levels are associated with early pregnancy loss (Zini et al., 2008). Therefore, ICSI success 
rates are sometimes adversely affected by sperm DNA damage, but at a later stage. In fact, 
Robinson et al. (2012) reported that high levels of sperm DNA damage are associated with 
increased risk of pregnancy loss regardless of the in vitro technique applied.  
Despite the large number of controversial studies, more studies should be done to limit the degree 
of uncertainty on these issues and to establish robust clinical test systems.  
 
1.3.4.5 Treatment modalities for high levels of sperm DNA damage 
Pons and colleagues (2013) reported that sperm DNA fragmentation can be decreased by 
reducing the days of sexual abstinence to only one abstinence day. They suggested that reducing 
Stellenbosch University  https://scholar.sun.ac.za
26 
 
the time of abstinence can be a simple, low-cost and non-invasive technique to reduce DFI in 
comparison with strategies like antioxidants, antibiotics, testicular biopsy, magnetic activated cell 
sorting (MACS), hyaluronic acid binding (physiologic ICSI) or intracytoplasmic morphologically 
selected sperm injection (IMSI). However, it is known that when the abstinence time is reduced, the 
volume, concentration and motility will diminish (Pons et al., 2013). 
 
a) Antioxidants and antibiotics  
Some studies have reported improved sperm DNA integrity with the use of oral antioxidants (Geva 
et al., 1998; Comhaire et al., 2000; Greco et al., 2005a), but few of these studies reported on the 
effect of pregnancy rates. Before one can reach any definite conclusion on the clinical usefulness 
of antioxidants in treatment of male infertility, large, prospective, randomized control studies will be 
necessary (Schulte et al., 2010). More information is also required about which antioxidants are 
more successful and which patients will benefit from its use. Furthermore, antibiotics are effective 
in reducing the DFI when it is raised due to an infection (Gallegos et al., 2008). Reducing the 
abstinence period may be a co-treatment, since the contact time between spermatozoa and 
leucocytes will be reduced (Pons et al., 2013).  
 
b) Testicular biopsy 
Greco and colleagues (2005b) reported a statistical significant increase in pregnancy (44.4% vs. 
5.6%) and implantation rate (20.7% vs 1.8%) with the use of testicular spermatozoa compared to 
ejaculated spermatozoa in males with increased DFI. However, this technique is invasive and it 
also provides immature spermatozoa for ICSI which have been suggested have an inferior ability to 
produce normal zygotes (Palermo et al., 1995b).  
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c) Magnetic activated cell sorting (MACS) 
Magnetic activated cell sorting (MACS) allows the reduction of both apoptotic sperm and DFI (Said 
et al., 2008; Rawe et al., 2010). This magnetic separation technique is not yet routinely used, since 
it requires expensive equipment and its secondary effect on spermatozoa is still unknown. Another 
limitation is that MACS separate apoptotic sperm cells, but fragmented spermatozoa that have not 
yet started apoptosis may be present. These cells would not be retained by the column and would 
still be available for the use in ART.  
 
d) Physiologic ICSI  
During in vivo fertilization hyaluronic acid (HA), secreted by the cumulus cells, plays a vital role in 
the selection of mature spermatozoa that will penetrate the zona pellucida and fertilize the oocyte. 
Parmegiani et al. (2010a) reported that the use of HA to select mature spermatozoa appears to be 
another way of treating patients with a high DFI. However, this technique can only be applied in 
ICSI cases. Two ready-to-use sperm-HA binding selection systems that have received the CE 
mark, indicating their conformity with health and safety requirement in the European Economic 
Area, as well as FDA (Food and Drug Administration) clearance, are currently available. One being 
the PICSI® Sperm Selection Device (MidAtlantic Devices, Origio, Harrilabs, South Africa) and the 
other being SpermSlowTM (MediCult, Origio, Harrilabs, South Africa). The PICSI® Sperm Selection 
Device is a plastic culture dish with microdots of HA hydrogel attached to the bottom of the dish, 
while SpermSlowTM is a viscous medium containing HA.  
Mature spermatozoa that bind to HA in vitro, are viable spermatozoa having completed the 
spermiogenetic process of plasma membrane remodelling, cytoplasmic extrusion and nuclear 
maturation (Huszar et al., 2003). Furthermore, these spermatozoa show low chromosomal 
aneuploidies and DNA fragmentation, and good nuclear morphology (Jakab et al., 2005). It has 
been reported that HA sperm selection for ICSI contribute to improved embryo quality, fertilization 
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rate, implantation rate, pregnancy rate and reduce miscarriage rate (Nasr-Esfahani et al., 2008; 
Parmegiani et al., 2010a; Worrilow et al., 2010). 
 
e) Intracytoplasmic morphologically selected sperm injection (IMSI) 
In 2001, Bartoov et al. introduced the motile-sperm organelle morphology examination (MSOME) 
by which the fine nuclear morphology of unstained motile spermatozoa is examined in real time 
using an inverted light microscope, equipped with high power optics enhanced by digital imaging, 
to achieve a total magnification of over 6000x. MSOME assess six sperm organelles, the 
acrosome, post-acrosomal lumina, neck, tail, mitochondria and nucleus, of which the sperm 
nucleus seems to be the most important. According to Bartoov et al. (2002) the morphological 
normalcy of the nucleus is analysed in terms of shape (smooth, symmetric and oval) and chromatin 
content (vacuole occurrence). Although the origin of sperm nuclear vacuoles is still unknown, 
studies reported that the presence of large vacuoles in motile spermatozoa are related to male 
subfertility (Mundy et al., 1994), and higher incidence of chromosomal, chromatin packaging and 
DNA abnormalities (Boitrelle et al., 2011; Perdrix et al., 2011; Wilding et al., 2011; Cassuto et al., 
2012). In contrast, several authors suggested that sperm vacuoles should be regarded as normal 
features of the sperm head (Pedersen, 1969; Watanabe et al., 2011; Tanaka et al., 2012).  
The incorporation of MSOME together with a micromanipulation system has introduced a modified 
ICSI method called intracytoplasmic morphologically selected sperm injection (IMSI). This 
technique requires a high level of technical expertise and inter-observer reproducibility (Said and 
Land, 2011). IMSI allows embryologists to identify subtle sperm morphology features, such as 
abnormal head size, midpiece defects and the presence of vacuoles, and select motile 
spermatozoa with an ideal morphology for oocyte injection.  
Various studies compared ICSI versus IMSI outcomes and found that IMSI significantly improves 
the percentage of top-quality embryos, implantation and pregnancy rates, and significantly reduced 
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miscarriage rate when compared with ICSI (Bartoov et al., 2003; Hazout et al., 2006; Antinori et al., 
2008; Vanderzwalmen et al., 2008; Wilding et al., 2011). They believed that these findings can be 
explained by the fact that during conventional ICSI, sperm morphology assessment takes place at 
only 400x magnification, while IMSI enables sperm selection higher than 6000x magnification. A 
mock ICSI trial by Wilding and colleagues (2011) determined that 64.8% of spermatozoa selected 
for conventional ICSI, had morphological abnormalities and would not be selected for IMSI.  
The paternal effect phenomenon refers to sperm-derived factors that can influence preimplantation 
embryo development (Shoukir et al., 1998; Tesarik et al., 2004). This effect may display early at 
the zygote stage, which is known as the early paternal effect. Studies however also demonstrated 
that the paternal effect can negatively influence preimplantation embryo development and clinical 
outcomes in the absence of any detectable impairment in zygote development. This is referred to 
as the late paternal effect (Tesarik et al., 2004). Sperm vacuoles have been found to be negatively 
correlated with IMSI outcome (pregnancy, implantation and live-birth rates). This suggests that 
sperm vacuoles are related to the late paternal effect (Greco et al., 2013). 
Recently Cassuto et al. (2014) conducted a prospective population-based study to investigate the 
major malformation rate of children born after ICSI and IMSI. They found a significant lower 
incidence of major birth defects in children born after IMSI (1.33%) compared with those born from 
ICSI (3.8%).  
However, like most scientific research, results are controversial. Several authors observed no 
statistical significant difference in any of the outcomes when IMSI and ICSI were compared (Mauri 
et al., 2010; Balaban et al., 2011; Knez et al., 2011; Oliveira et al., 2011; Setti et al., 2011). It has 
been proposed that these conflicting results might be due to differences in inclusion criteria, 
simulation protocols, seminal and oocyte qualities and many other variables within the IVF cycle 
(Setti et al., 2013). A Cochrane Review done in 2013 included only randomised control trials 
comparing ICSI and IMSI. It was concluded that the results do not support the clinical use of IMSI 
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and that further trials are necessary to improve the evidence quality before IMSI can be 
recommended in clinical practice (Teixeira et al., 2013). Furthermore, De Vos and colleagues 
(2013) stated that IMSI is a time-consuming procedure at the expense of oocyte ageing and the 
lack of proof and understanding of its benefit does not justify its routine clinical application at 
present. Since IMSI‟s priority over ICSI is still under debate, a literature review concluded that the 
only confirmed indication for IMSI is recurrent implantation failure following ICSI. All of the other 
potential indications of IMSI require further investigation (Boitrelle et al., 2014).  
 
1.3.5  ICSI technique 
Although the technique of ICSI appears to be simple, it involves the expertise of a trained 
embryologist, sophisticated instruments, fine glass needles and pipettes, as well as an inverted 
microscope with a heated stage. Since ICSI is an invasive assisted reproduction technique, the use 
of good quality micro-tools is important for minimal trauma to the oocyte and optimal results (Clarke 
et al., 1988). Today ICSI micro needles are supplied by numerous companies and are globally and 
commercially available. 
 
1.3.5.1  Sperm immobilization 
Many scientists have described the importance and necessity of the spermatozoon plasma 
membrane damage process prior to ICSI (Dozortsev et al., 1995b; Gerris et al., 1995; Van den 
Bergh et al., 1995; Palermo et al., 1996). The technique causes destabilization and increased 
permeabilization of the spermatozoon‟s membrane that induce changes in the acrosome and 
sperm head plasma membrane (Fishel et al., 1995; Palermo et al., 1996 Takeuchi et al., 2004). It is 
also believed that this immobilization process induces the release of spermatozoon-associated 
oocyte activating factors, such as oscillin, into the ooplasm that will lead to the initiation of calcium 
oscillations and subsequent oocyte activation (Dozortsev et al., 1995b; Parrington et al., 1996; 
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Palermo et al., 1997). Tesarik et al. (1994) alsoreported that the depolymerisation of the 
spermatozoon‟s membrane is necessary for sperm nucleus decondensing factors (SNDF), 
released from the ooplasm, to reach the spermatozoon‟s nucleus in order to initiate chromatin 
decondensation and pronuclei formation. The immobilization of the spermatozoon may also 
prevent the interference of the spermatozoon with the cytoskeleton and metaphase spindle of the 
oocyte. However, Vanderzwalmen et al. (1996) speculated that the process of aspiration of the 
cytoplasm may be more deleterious for the organelles inside the cytoplasm, than the possible 
damage that a motile spermatozoon can cause. The immobilized spermatozoon may also be 
injected into the ooplasm with less medium than required than more motile spermatozoa.  
Several immobilization techniques can be used to induce sperm membrane permeabilization. The 
conventional method consists of striking the tail of the spermatozoon against the bottom of the dish 
with the micro injection needle until a clear bend in the tail is seen (Palermo et al., 1996). Other 
more aggressive techniques include: permanently crimping the tail in the mid-piece region 
(Palermo et al., 1996), cutting the tail below the mid-piece region (Fishel et al., 1995), between the 
head and the tip of the tail (Gerris et al., 1995), or at the tip of the tail (Chen et al., 1996) and also 
the application of lasers (Debrock et al., 2003) or piezo-pulses (Yanagida et al., 1999) to sperm 
tails. Higher post ICSI fertilization rates after more aggressive mechanical (Fishel et al., 1995; van 
den Bergh et al., 1995) or piezo-pulse induced (Yanagida et al., 1999) sperm immobilization 
compared to the conventional method have been reported. However, a more recent randomised 
control trial by Velaers et al. (2012) compared the triple touch with the single touch sperm 
immobilization technique and found that the triple touch technique had no advantages compared to 
the single touch technique. They speculated that the amount of damage needed to immobilize a 
motile spermatozoon is not dependant on the number of strokes, but rather on the region where 
the spermatozoon is immobilized. Sathananthan (1999) reported that the spermatozoon‟s neck and 
proximal midpiece region should be kept intact, since the centrosome is located beneath the basal 
plate of the spermatozoon‟s head. The sperm centrosomal material contains centrioles and 
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centrosomal components onto which oocyte centrosomal proteins assemble after sperm 
incorporation to form the sperm aster that is essential for uniting sperm and oocyte pronuclei 
(Schatten and Sun, 2009). This organelle contributes to the assembly of microtubule within the 
penetrated oocyte, which contributes to the formation of the first mitotic spindles during the initial 
fertilization phase and initiates embryonic cell division.  
 
1.3.5.2  Oocyte position during microinjection 
One of the important technical parameters of ICSI is the awareness of the Metaphase-II spindle 
location during the injection procedure. It is believed that the meiotic spindle with metaphase II 
chromosomes is located in the periphery of the ooplasm subjacent to the first polar body (Cohen et 
al., 1998). Therefore, the polar body marks the approximate spindle location. It became traditional 
to position the oocyte with the first polar body at the 6 or 12 o‟clock position and inject the 
spermatozoon into the oocyte at the 3 or 9 o‟clock position (Lanzendorf et al., 1988; Van 
Steirteghem et al., 1993) with the opening of the needle away from the polar body position. These 
orientations stabilized the presumed spindle position farthest from the path of the injection needle, 
aiming to minimize the potential for spindle damage. In contradiction, studies have found that the 
first polar body does not accurately predict the location of the metaphase II meiotic spindle (Silva et 
al., 1999). However, one of the suggested reasons is that the polar body can be displaced from its 
original extrusion site during the manipulation required for cumulus and corona removal (Rienzi et 
al., 2003).  
 
1.3.5.3  Oocyte ooplasm aspiration 
A technique which dramatically increased success rates, involves the aspiration of the ooplasm just 
before sperm injection (Van Steirteghem et al., 1993; Van Steirteghem et al., 1994). This causes 
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the oolemma to rupture and Ca2+ to be released, which facilitates and assists oocyte activation 
(Tesarik and Sousa, 1995; Ebner et al., 2004; Vanden Meerschaut et al., 2014).This technique 
also ensures that the oocyte is penetrated and that the spermatozoon will be deposited into the 
ooplasm and not into the perivitelline space.  
Cytoplasmic aspiration may be influenced by the oocyte quality and maturity, as well as the type of 
microtool used (Vanderzwalmen et al., 1996).  
 
1.3.5.4  Head first or tail first sperm injection 
Traditionally an immobilized spermatozoon is aspirated into the injection pipette tail first, so that it 
can be microinjected head first into to ooplasm. The rationale for this may however be questioned 
since ICSI bypasses the steps involved with normal fertilization for which sperm direction is 
necessary. A study done by Woodward et al. (2008) showed that the direction of sperm 
microinjection at ICSI appears to have no effect on fertilization or development, provided that the 
sperm is successfully deposited into the ooplasm without damage to the oocyte. Although studies 
concluded that sperm head or tail first injection into the ooplasm does not affect human oocyte 
survival, fertilization or embryo development (Suh et al., 1997; Hiraoka et al., 2014), Woodwardet 
al. (2008) discussed that the embryologist may prefer to microinject spermatozoa head first purely 
for technical reasons, rather than biological considerations. Since the sperm head is larger than the 
tail and more visible under standard microscopy, the head first injection method may allow for more 
precise placement of the sperm head at the tip of the injection pipette just before ICSI. This will 
allow greater precision than the tail first microinjection and may assist the scientist in injecting as 
little as possible medium into the oocyte during ICSI. Some also believe that by injecting the 
spermatozoon head first, the head will serve as an anchor and prevent the spermatozoon to be 
drawn out from the ooplasm with the injection pipette after microinjection (personal communication; 
Mr GM Tinney-Crook). However, there is a lack of published information with regards to this theory. 
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1.4  The role of PVP during ICSI 
Polyvinylpyrrolidone, also known as PVP, is widely and commonly used in a variety of applications 
in the fields of medicine, pharmacy, cosmetics and industry (Sanner and Straub, 1985). This 
synthetic, viscous medium is commercially available from most companies supplying ART media. 
PVP (7-10%) is routinely used during ICSI to facilitate the handling, manipulation and slowdown of 
spermatozoon movement during the immobilization process (Gerris and Khan, 1987; Akerlöf et al., 
1991). It is also part of density gradients such as Sil-Select®.  
Since the introduction of ICSI for human ART, more than five thousand ICSI babies have been 
born annually in the United Kingdom (NHS Lothian, 2012). This data clearly suggest that the 
embryo can develop to fetal stages and into a healthy child following the injection of spermatozoa 
and a small volume of PVP into the oocyte during ICSI. However, various studies have reported 
adverse effects as a result of its in vivo and in vitro use. It is thus vital to confirm the safety of PVP 
application for human ART. 
Research has shown that PVP stabilizes the sperm plasma membrane (Dozortsev et al., 1995a), 
causing a delay in calcium oscillations in the sperm-penetrated oocyte and resulting in a delayed 
fertilization process. Other studies indicated a prevention of nuclear decondensation (Clarke et al., 
1988; Dozortsev et al., 1995b) and DNA lesions (Ray et al., 1995). However, researchers found 
that PVP reduce bull sperm membrane integrity (De Leeuw et al., 1993) and is toxic when injected 
into mouse zygotes (Bras et al., 1994). Palermo et al. (1995b) also suggested that when injecting 
oocytes, as little as possible medium should be injected together with the spermatozoon into the 
ooplasm, since this can lead to swelling of the oocyte and be deleterious as well as reduce the 
chance of sperm decondensation. Although Motoishi et al. (1996) and Saha et al. (1996) 
concluded that PVP is neither detrimental to bovine embryonic development nor to embryo quality, 
it is believed that since PVP is a large polymer, it probably cannot diffuse out of the oocyte or be 
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digested by lysosomal enzymes and will remain in the oocyte for a prolonged period. (Jean et al., 
2001)  
With the use of transmission electron microscopy, Strehler et al. (1998)found that the exposure of 
sperm to PVP cause sub-microscopic changes in the sperm structure. Damage in the sperm 
nucleus was observed, both in terms of shape and texture of chromatin, which was frequently 
decondensed. They speculated that the nuclear deterioration was caused by a general breakdown 
of sperm membranes, and subsequently necrotic processes. Their findings contradicted the theory 
proposed by Clarke et al. (1988) and Dozortsev et al. (1995a) that PVP stabilizes the plasma 
membrane of spermatozoa. It is also believed that the detrimental effects of PVP on spermatozoa 
are dependent on the length of exposure time (Kato and Nagao, 2009) during the sperm selection 
and immobilization process of ICSI.  
 
1.5 Alternative PVP free ICSI methods  
It is clear that there are some concerns about the safety of the usage of PVP in ART. To eliminate 
the potential damaging effect of PVP, various techniques have been developed which do not 
necessitate slowing sperm motility (Harari et al., 1995; Hlinka et al., 1998; Tsai et al., 2000). 
However, the absence of PVP made the ICSI procedure more laborious and difficult for trained 
embryologists since fast swimming spermatozoa were difficult to immobilise. Therefore, an 
alternative medium to PVP has been sought for reducing spermatozoon motility.  
Barak et al. (1999; 2001) advocated that hyaluronic acid (HA) could be used as a physiological 
replacement for PVP. HA is a natural readily degradable glycosaminoglycan component of the 
extracellular matrix of the cumulus oophorus surrounding the oocyte. As previously described, HA 
seems to play a pivotal role in the physiological sperm selection process, since it only enables 
mature spermatozoa with a high affinity of HA receptor to bind and eventually penetrate the zona 
pellucida and fertilize the oocyte. They reported similar fertilization and pregnancy rates after ICSI 
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with sperm exposed to either HA or PVP. Several authors also have observed that HA-containing 
products have no negative effect on postinjection zygote development and can be metabolised by 
the oocyte (Barak et al., 2001; Balaban et al., 2003); unlike what is believed for PVP.  
 
1.5.1  SpermSlowTM 
Recently ORIGIO® released a natural biodegradable alternative to PVP; SpermSlowTM (Medicult, 
Origio, Harrilabs, South Africa). This viscous medium is one of the two ready-to-use systems (the 
other being the PICSI® Sperm Selection Device) specially designed for sperm-HA binding selection 
that have received the CE mark, indicating their conformity with health and safety requirement in 
the European Economic Area, as well as FDA clearance. A prospective randomized control trial 
compared these two systems and found that both PICSI®and SpermSlowTM allow comparable 
clinical efficiency in selecting HA-bound spermatozoa (Parmegiani et al., 2012). The only 
significant difference observed, was the ICSI procedure duration which was almost three times 
longer in the PICSI® group. Since the design of the two systems differs, mature HA-bound 
spermatozoa have a different appearance. PICSI® HA-bound spermatozoa are bound by the head 
to the bottom of the dish, spin around their heads with vigorous tail motility and can be selected by 
their degree of motility. SpermSlowTM HA-bound spermatozoa on the other hand, appear to be 
slowed with stretched tail appearance and narrow beat amplitudes. HA-unbound spermatozoa are 
less slowed down by the viscous medium and swim around with wider tail-beat amplitude. Specific 
training is needed to recognize this motility pattern (Parmegiani et al., 2012). SpermSlowTM is more 
versatile than PICSI® in that it can be used on a glass-bottom culture dish for high-magnification 
microscopy. This procedure would then be called physiologic IMSI (Parmegiani et al., 2010a).  
Since SpermSlowTMmainly consists of HA, it is said to be a safer alternative to PVP (Parmegiani et 
al., 2010a). In SpermSlowTM, mature sperm cells‟ heads bind to the HA via HA receptors and is 
effectively slowed down and could be visualized for IMSI. Parmegiani et al. (2010a) conducted a 
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study by using SpermSlowTMfor ICSI. SpermSlow-bound spermatozoa showed a significant twofold 
reduction in sperm DNA fragmentation rate compared with spermatozoa recovered from PVP. By 
favouring selection of spermatozoa with normal nucleus and intact DNA, a statistical significant 
improvement in embryo quality and development were observed when oocytes were injected with 
SpermSlowTM-selected spermatozoa. They also demonstrated that HA may help to select a 
subpopulation of spermatozoa with normal nuclei, thus speeding up the time-consuming IMSI 
procedure. A trend towards better fertilization, pregnancy and implantations in the SpermSlowTM-
ICSI group was observed, however, these findings were not significant. With a large retrospective 
comparison of SpermSlowTM-ICSI versus conventional PVP-ICSI, Parmegiani et al. (2010b) 
confirmed their initial observation. They reported a trend towards better fertilization, pregnancy and 
abortion rates in the SpermSlowTM-ICSI group. Furthermore, injection of SpermSlowTM-bound 
spermatozoa significantly improved embryo quality and implantation rates.  
In contrast, some authors found no statistically significant differences in fertilization rates, embryo 
quality, pregnancy rates or implantation rates when comparing SpermSlowTM-ICSI with 
conventional PVP-ICSI treatments (Van Den Berg et al., 2009; Ménézo et al., 2010). At the very 
least, in all of the studies HA-sperm injection never caused a detrimental effect on ICSI outcome 
parameters.  
 
 
1.6 IMSI StrictTM 
Hamilton Thorne IVOS® developed an automated software solution for live sperm morphology 
evaluation under high magnification, called IMSI StrictTM. It combines Tygerberg Strict Criteria 
morphological classification of human spermatozoa (Kruger et al., 1986) with motile sperm 
organelle morphology examination (MSOME) and provides software-based categorization (IMSI 
StrictTM brochure, 2013). As discussed previously, IMSI is based on MSOME where the 
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examination of motile spermatozoa is performed in real time using an inverted light microscope 
equipped with high power optics enhanced by digital imaging. The IMSI StrictTM software was 
developed to aid in the IMSI spermatozoon selection process by measuring the size and shape of 
the spermatozoon head, detecting mid-piece abnormalities and identifying vacuoles on the live 
sperm sample. This software enables objective classification of spermatozoa that removes inter-
technician variation. The analysis does not require manual measurements of spermatozoa and 
produce immediate results. Currently this software is available for research use only and not used 
for diagnostic purposes (IMSI StrictTM brochure, 2013).  
For good optics and spermatozoon evaluation in IMSI StrictTM, spermatozoa need to be moving 
very slowly or be immotile, but still viable. This will be achieved by either incubating spermatozoa in 
PVP or SpermSlowTM medium for a substantial time period. Before marketing the clinical use of 
IMSI StrictTM, the possible toxicity or deleterious effect of PVP and SpermSlowTM on spermatozoa 
needs to be excluded. There are conflicting data regarding the effect of these two mediums on 
spermatozoon parameters. Salian et al. (2012) reported a significant increase in sperm DNA 
fragmentation when spermatozoa were incubated with PVP, while spermatozoa incubated with 
SpermSlowTM did not induce DNA damage. In contrast, Rougier and colleagues (2013) reported 
that spermatozoa incubated with PVP and SpermSlowTM showed similar increases in sperm DNA 
fragmentation over time. This analytical study evaluated the possible effect of PVP and 
SpermSlowTM on human spermatozoa.  
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1.7 Objectives of this study 
The primary objective of this study was to evaluate the possible effect of 7% Ready-to-use PVP 
Solution (SAGE, Cooper Surgical, Harrilabs, Paulshof, South Africa) and SpermSlowTM (Origio, 
Cooper Surgical, Harrilabs, Paulshof, South Africa) on human spermatozoa after different 
incubation periods using a viability stain, CASA motility and kinetic parameters, chromatin 
packaging analysis (CMA3 staining analysis) and DNA fragmentation analysis (TUNEL analysis).  
The secondary objective was to evaluate the possible effect of 7% Ready-to-use PVP Solution 
(SAGE, Cooper Surgical, Harrilabs, Paulshof, South Africa) and SpermSlowTM (Origio, Cooper 
Surgical, Harrilabs, Paulshof, South Africa) on human spermatozoa‟s ultrastructure with 
Transmission Electron Microscopy (TEM) after one hour incubation period.  
 
 
1.8  Hypothesis 
It was hypothesized that PVP and SpermSlowTM will perform the same (thus be equivalent) in all 
tested outcomes and will not be detrimental to sperm viability, motility, ultrastructure, chromatin 
packaging or DNA fragmentation.  
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CHAPTER 2  
Materials and Methods 
 
2.1  Study population and semen sample collection 
This prospective analytical study was conducted at Drs Aevitas Fertility Clinic(Vincent Pallotti 
Hospital, Cape Town, South Africa) as well as the Fertility Unit at Tygerberg Hospital (Cape Town, 
South Africa) between July 2013 and October 2014. The Health Research Ethics Committee 
(HREC) of the University of Stellenbosch approved the study protocol (Ethics Reference number: 
S13/05/114). A total of 90 semen samples without duplication were analysed for the quantitative 
analysis (Experiment A) and 1 sample for the descriptive analysis (Experiment B). Excess semen 
from routine semen analysis samples, that would normally be discarded, was used in this study. It 
must be noted that semen samples used in this study was not used for any ART procedures 
(ICSI/IVF/IUI). For this reason, the HREC approved a waiver of consent for the semen samples 
that were used for this study.  
After semen samples were collected by masturbation, it was allowed to liquefy at 37°C. Routine 
semen analysis (see Addendum II),using the World Health Organization (WHO, 2010) as guideline, 
was performed to decide whether to include the semen sample in this study. Samples with one or 
more of the following properties were excluded from the study: 
1) <1ml semen 
2) increased viscosity (≥10cm) 
3) <40% motility 
4) <2+ forward progression  
5) <50x106/ml spermatozoa (concentration after swim up of ≥20x106/ml ideally needed) 
6) increased amount of debris and cells in semen sample 
7) HIV positive samples 
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2.2  Semen sample preparation and handling 
The excess semen from samples used for routine semen analysis was used and prepared with a 
routine swim up method (see Addendum III) as for ART. Modified Tygerberg Hospital andrology 
manual based on WHO (2010) was used as guideline for the preparation of semen. Spermatozoa 
swam up in 1ml Quinn‟s Sperm Washing medium (SAGE, Cooper Surgical, Harrilabs, South 
Africa). The exclusion criteria were chosen in order to obtain an ideal swim up concentration of 
≥20x106/ml. 
Nine 1,5ml Eppendorf tubes were labelled as P1, P2, P3, S1, S2, S3, C1, C2 and C3. 80µl of 7% 
Polyvinylpyrrolidone (PVP) medium (SAGE, Cooper Surgical, Harrilabs, South Africa) was 
aliquoted into tubes P1-P3. 80µl of SpermSlowTM medium (Origio, Cooper Surgical, Harrilabs, 
South Africa) was aliquoted into tubes S1-S3. Tubes C1-C3 contained 80µl aliquots of Sperm 
Washing medium and acted as the control group. All mediums were kept at room temperature. 
80µl of the swum up sperm sample were mixed and incubated at 37°C with the above mentioned 
mediums in the nine separate Eppendorf tubes. Tubes P1, S1 and C1 were incubated for 5 
minutes, tubes P2, S2 and C2 for 30 minutes and tubes P3, S3 and C3 were incubated for 60 
minutes (see Addendum IV).  
After the respective incubation periods, each sample was washed to remove the PVP and 
SpermSlowTM medium. 500µl Sperm Washing medium was added to every sample (including the 
control samples) after which it was centrifuged (450g, 5minutes). The resulting pellet was 
resuspended in ≥50µl Sperm Washing medium. The volume of the Sperm Washing medium used 
for resuspension was calculated for each sperm sample to achieve a final sperm concentration of 
±20x106/ml.  
After resuspension, the quantitative (Experiment A) and descriptive (Experiment B) analyses were 
done on the nine different sperm solutions.  
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2.3  Experiment A 
2.3.1  Computer assisted semen analysis (CASA) - Motility analysis 
A standardized method for spermatozoa motility determination was followed using the Hamilton 
Thorn CASA system (IVOS® Hamilton Thorne CASA system equipped with HT-CASA II software 
version 1.1). The nine different sperm solutions per semen sample were loaded onto a labelled 
Leja® slide with a fixed, consistent chamber depth (Tomlinson et al., 2001) and inserted into the 
CASA system for the motility analyses (see Addendum V). The following additional spermatozoa 
motion parameters were also analysed and notated for all the sperm samples: Curvilinear velocity 
(VCL); Average path velocity (VAP); Straight-line velocity (VSL); Amplitude of lateral head 
displacement (ALH); Beat cross frequency (BCF); Linearity (LIN) and Straightness (STR). A total of 
90 semen samples were analysed. 
 
2.3.2  Viability stain analysis 
The viability stain analysis is a test to determine the percentage of viable spermatozoa by 
assessing the membrane integrity of the cells. This staining technique uses eosin (Merck, 
Modderfontein, South Africa) as a vital stain. This method is based on the principle that damaged 
plasma membranes, such as non-vital spermatozoa, allow entry of this membrane-impermeant 
stain. Nigrosin (Merck, Modderfontein, South Africa) is used to increase the contrast between the 
background and the sperm heads. This makes it easier to discern faintly stained spermatozoa. It 
also permits slides to be stored for re-evaluation and quality control purposes (Björndahl et al., 
2003). 
With bright field optics, viablespermatozoa have white or light pink heads and dead spermatozoa 
have heads that are stained red or dark pink. If the stain is limited to only a part of the neck region, 
and the rest of the head area is unstained, this is considered a „leaky neck membrane‟. This is not 
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a sign of cell death and total membrane disintegration and these cells should be assessed as 
viable. 
Frosted slides were labelled according to the sample number and the nine sperm solutions (P1-P3, 
S1-S3, C1-C3) per semen sample. The spermatozoon viability stain was done on each sperm 
solution (see Addendum VI). Modified Tygerberg Hospital andrology manual based on WHO 
(2010) was used as guideline for the spermatozoon viability stain. A total of 100 spermatozoa were 
randomly assessed for each sperm solution slide using a light microscope with the 100x oil 
immersion lens. A percentage of viable spermatozoa (not stained, white spermatozoa) were 
notated. A total of 90 semen samples were analysed. 
 
2.3.3 Chromomycin A3 (CMA3) staining test 
As previously discussed in the introduction, CMA3 is a guanine-cytosine-specific fluorochrome that 
exposes chromatin that is poorly packaged via direct visualization of protamine deficient loosely 
packaged chromatin (Bianchi et al., 1996). The CMA3 and protamines compete for the same 
binding sites (minor groove) in the DNA. A previous study my Manicardi et al. (1995) found a 
strong correlation between sensitivity to CMA3 staining and sensitivity to endogenous in situ nick 
translation.  
Smears of each of the nine test sperm solutions per semen sample were made for the CMA3 
staining test (see Addendum VII). The slides were allowed to air dry and were fixed for 20 minutes 
in methanol/acetic acid. Following the fixation, slides were stained with 15µl CMA3 staining medium 
(Sigma-Aldrich, Johannesburg, South Africa) and kept in a dark chamber for 20 minutes. Slides 
were then rinsed in McIlvaine‟s buffer and mounted with Dabco anti-fade solution (Sigma-Aldrich, 
Johannesburg, South Africa). An Olympus BX40 fluorescence microscope (Wirsam Scientific, 
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Cape Town, South Africa), equipped with the appropriate filter and excitation of 465-495nm was 
used for the slide evaluation (Esterhuizen et al., 2000).  
A total of 100 spermatozoa were randomly assessed for each sperm solution slide. Bright yellow 
stained spermatozoa (CMA3 positive) were regarded as immature spermatozoa with decondensed 
chromatin. Spermatozoa with dull yellow staining (CMA3 negative) contained good chromatin 
packaging and were therefore regarded as mature spermatozoa. Chromatin packaging of samples 
with CMA3 values of ≤40% were considered as normal. Values of 41-60% were considered as 
dubious abnormal chromatin packaging and values ≥61% were considered as abnormal sperm 
chromatin packaging (Esterhuizen et al., 2000). A total of 90 semen samples were analysed. 
 
2.3.4  Terminal deoxynucleotidyl transferase dUTP nick-end labelling (TUNEL) assay  
  - Epi-fluorescence 
As previously discussed in the introduction, TUNEL determines the existing DNA damage of 
spermatozoa and is based on the ligation of labelled dUTP-nucleotides to the 3‟-OH phosphate 
ends of single- as well as double-stranded DNA breaks (Nakamura et al., 1995). This reaction is 
catalysed by the template-independent enzyme, terminal deoxynucleotidyl transferase (TdT). By 
using labelled dUTP-nucleotides, DNA fragmentation in spermatozoa can be identified by using 
bright field microscopy, fluorescent microscopy as well as flow cytometry (Gorczyca et al., 1993a; 
Muratori et al., 2010). Spermatozoa with normal DNA have only background staining, while those 
with fragmented DNA (multiple chromatin 3‟ –OH ends) stain brightly (Gorczyca et al., 1993a).  
An aliquot (≥30µl) of each of the nine test sperm solutions per semen sample was frozen in liquid 
nitrogen using a custom made storage device consisting of microtips sealed with high security 
CBS® straws (see Addendum VIII). The tips were labelled and directly dunked into the nitrogen 
after each time interval. The tips were stored in a nitrogen tank reserved for experimental samples 
only.  
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Sperm DNA fragmentation was assessed using a modified method previously described by 
Avendaño et al. (2010). Dr Venesa Y. Rawe (Centro de Estudios de Gynecología y Reproducción, 
Buenos Aires, Argentina)was also contacted in connection with the TUNEL methodology and 
evaluation. The In Situ Cell Death Detection Kit, Fluorescein (Roche Diagnostics, Mannheim, 
Germany) was used for the analysis. The kit contains an enzyme solution (TdT) that catalyse the 
addition of the label solution (fluoresceine-dUTP) at free 3‟-OH groups in single- and double-
stranded DNA that allows the detection of single- and double-stranded DNA breaks that occur at 
the early stages of apoptosis.  
Since we had limited funding for reagents as well as limited time to do the analyses, it was decided 
to only assess 29 of the 90 sperm samples at two time intervals (30 and 60 minutes). These sperm 
samples were randomly selected. Test sperm solutions were thawed for 10 minutes at 37°C and 
pipetted onto two duplicate 21 well Teflon printed diagnostic slides (Protea Laboratory solutions, 
Johannesburg, South Africa). One of the slides was kept as a back-up. The slides were allowed to 
air dry.  
4% Formaldehyde/PBS solution was used as a fixative by adding 5µl to each well and incubating 
the slide for 45 minutes at room temperature in a humidified chamber. After the incubation period, 
the fluid form each well was slowly siphoned by using cut tissue paper pieces. Each well was 
washed with 10µl of 1% HSA/PBS solution after which the fluid was siphoned again.  
Spermatozoa were permeabilized with 5µl of 0.1% Triton X-100/PBS for 10 minutes at room 
temperature in a humidified chamber. Again the fluid was siphoned from each well and the wells 
were washed twice, siphoning between each washing step.  
After siphoning the fluid from each well after the second washing step, 5µl of the Roche kit label 
solution was pipetted onto one of the wells. This well served as a negative control. 10µl Roche kit 
enzyme solution was then mixed with 90µl Roche kit label solution and 5µl of this reaction mixture 
was carefully pipetted onto the remaining 20 wells. The slide was incubated for 90 minutes at 37°C 
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in a dark humidified chamber. After the incubation period the wells were siphoned, washed twice 
and siphoned again. Dabco anti-fade solution was added to the slide and it was covered with a 
coverslip.  
Slides were analysed immediately. A total of 100 spermatozoa were randomly assessed in each 
well under a fluorescence microscope (Olympus BX40). Spermatozoa were classified according to 
intact or fragmented DNA. Spermatozoa showing no fluorescence had intact DNA (TUNEL 
negative spermatozoa), while spermatozoa with DNA damage fluoresced green (TUNEL positive 
spermatozoa). A sperm DNA status was seen as normal with TUNEL positive spermatozoa values 
≤30%. TUNEL values >30% indicated fragmented sperm DNA (Evenson et al., 1999; Henkel et al., 
2004).  
 
2.4  Experiment B 
2.4.1  Transmission Electron Microscopy (TEM) 
Three hundred micro liters (300µl)of the swum up sperm samplewas mixed with 300µl PVP, 
SpermSlowTM and Sperm Washing medium respectively to ensure enough sperm cells for the 
analyses. Only three test sperm solutions per semen sample (not nine as described in Experiment 
A) were prepared for TEM evaluation. These samples were incubated for one hour only. After the 
incubation period with PVP, SpermSlowTM and sperm washing medium, the samples were washed 
with 500µl sperm washing medium, centrifuged and the pellets were resuspended in 100µl sperm 
washing medium. These resuspended spermatozoa samples were carefully suspended into 2.5% 
Glutaraldehyde/PBS solution (Sigma-Aldrich, Johannesburg, South Africa) with a ratio of 1:5 (test 
sample:glutaraldehyde). Samples were stored at 4°C for 24 hours during which time a pellet 
formed at the bottom of each Eppendorf. These pellets were used for the Transmission Electron 
Microscopy (TEM) evaluation. TEM was done by Mrs. Nolan Muller (Anatomical Pathology – 
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Electron microscopy division) using a standard TEM technique. Evaluation of micrographs was 
done by expert, Prof M Sousa (University of Porto, Portugal). Prof Sousa previously collaborated 
with the Tygerberg Fertility Clinic in publishing an atlas (Shafie et al., 2000) on TEM images of 
human spermatozoa and unfertilized oocytes. Only one semen sample‟s micrographs were 
evaluated. 
 
2.5  Data management and statistical analysis 
A data sheet (see Addendum IX) was used to record all the relevant information. This information 
was transferred to a Microsoft Excel sheet in order for the statistical analysis to take place. The 
statistician, Prof Carl Lombard [The Biostatistics Unit of the South African Medical Research 
Council (MRC)] was consulted.  
Statistical analysis was carried out using the Stata version 13.0 software for Windows. A Binomial 
Regression Model with Chi-square tests was used for the viability, CMA3 and TUNEL parameters 
to estimate the difference in proportions between the two active mediums (PVP and SpermSlowTM) 
as well as the difference with the control (sperm washing medium). The denominator used for each 
sample was n=100. The statistical analysis was adjusted for correlated experimental design in a 
Population Averaged Model. The CASA parameters (motility and progressive spermatozoa 
percentage) were analysed as if they were a continuous variable using a Linear Regression Model. 
These analyses took the experimental design into account; the nine test sample replications within 
the same sperm donor. The within donor design also controls for the between donor variability. 
Good precision is thus achieved as is evident from the narrow confidence intervals of the contrast 
estimates. 
Statistical analyses with P-values of <0.05 were considered statistically significant. However, 
whether or not PVP andSpermSlowTM,sdata sets were equivalent had to be established. The 
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conventional significant test has little relevance in an equivalence trial. A failure to detect a 
difference does not imply equivalence (Altman et al., 1995). On the other hand, a detected 
difference may not have any clinical relevance and may correspond to practical equivalence. The 
confidence interval defines a range for the possible true difference between two treatments. If 
every confidence interval point within this range corresponds to a difference of no clinical 
importance, then only may the treatment be considered to be equivalent. Therefore, a range of 
equivalence had to be predefined and then it could be established whether the confidence interval 
(centred on the observed difference) lies within these set margins (Jones et al., 1996). Senior 
scientists in the reproductive biology field were approached to establish an equivalence margin for 
all the variables tested. Using the equivalence margins, it was possible to establish whether or not 
PVP and SpermSlowTM were clinically equivalent. The equivalence margins for sperm viability, 
motility and percentage progressive spermatozoa were set at ±20%. The equivalence margins for 
both CMA3 and TUNEL positive parameters were set at ±10%.  
The transmission electron microscopy (TEM) results were statistically analysed by Prof M Sousa 
through the IBM SPSS Statistics 20 program for Windows. Means were compared by the t-test for 
independent samples. Categorical variables were analysed using descriptive statistics and the Chi-
square test, with continuity correction. In some variables, in the presence of cells with expected <5 
value in contingency tables, the Fisher exact test was used. All statistical tests were two-tailed, with 
significance level of 0.05 (P-value <0.05). 
 
  
Stellenbosch University  https://scholar.sun.ac.za
49 
 
CHAPTER 3  
Results 
 
Average sperm parameters (semen volume, semen viscosity, sperm motility, sperm forward 
progression and sperm concentration) of the semen samples (n=90) used in the study is presented 
in Addendum X.  
 
3.1 Primary objective: The effect of PVP and SpermSlowTM on basic human semen 
parameters and sperm DNA integrity 
Descriptive statistics for the viability, CMA3 and TUNEL variables are presented in Table 3.1. 
Descriptive statistics for the motility and progressive sperm CASA (computer assisted semen 
analysis) variables are presented in Table 3.2. A Box-and-Whisker plot diagram was used for all 
the tested variables indicating the median, minimum and maximum parameters. The correlation 
between the incubation time and the tested variables was presented in a Lowess Smoother graph. 
The default bandwidth of 0.8 was used for all the Lowess Smoother graphs. 
 
Table 3.1 Descriptive statistics of sperm viability, CMA3 and TUNEL parameters after the 
incubation in PVP, SpermSlowTM and Sperm Washing medium for three incubation 
periods (5, 30 and 60 minutes). 
Method variable 
 
Viability (%) 
 
CMA3 (%) 
 
TUNEL (%) 
 
  Incubation 
time 
(minutes) 
Medium  Mean 
Standard 
Deviation 
Mean 
Standard 
Deviation 
Mean 
Standard 
Deviation 
5 
PVP  68.4 13.2  17.5 8.9  - - 
SS  62.7 14.1  16.8 9.0  - - 
SW  64.1 12.5  16.9 8.2  - - 
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PVP = PVP 7% Ready-to-Use solution; SS = SpermSlow
TM
; SW = Quinn‟s Sperm Washing Medium  
 
 
 
Table 3.2   Descriptive statistics of CASA variables after the incubation in PVP, 
SpermSlowTM and Sperm Washing medium for three incubation time periods 
(5, 30 and 60 minutes). 
PVP = PVP 7% Ready-to-Use solution; SS = SpermSlow
TM
; SW = Quinn‟s Sperm Washing Medium  
30  
PVP  67.4 13.3  18.2 8.1  11.6 7.8 
SS  61.2 12.8  17.2 8.9  12.1 5.5 
SW  62.4 12.6  18.0 8.3  11.9 7.4 
60  
PVP  63.0 14.6  19.1 9.4  10.9 6.2 
SS  59.4 13.0  17.1 8.1  13.4 7.5 
SW  58.9 12.6  17.1 8.4  11.8 6.7 
Method variable 
 CASA 
 Motility (%)  Progressive sperm (%) 
Incubation time 
(minutes) 
Medium  Mean 
Standard 
Deviation 
 Mean 
Standard 
Deviation 
5  
PVP  73.6 14.0  51.4 18.5 
SS  73.6 14.2  53.9 18.1 
SW  74.4 13.7  52.1 17.8 
30 
PVP  73.6 13.6  58.7 13.9 
SS  74.0 13.6  59.2 14.5 
SW  77.1 13.6  61.0 13.5 
60 
PVP  68.7 15.2  54.5 13.0 
SS  70.8 14.1  56.2 14.1 
SW  75.8 12.9  59.4 14.5 
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3.1.1 Sperm viability (n=90) 
Results for sperm viability (eosin viability analysis) after incubation are presented in Figure 3.1 and 
3.2.  
 
Figure 3.1  Box-and-Whisker plot diagram indicating sperm viability profile after the incubation in 
PVP, SpermSlowTM (SS) and Sperm Washing medium (SW) for the three time 
periods (5, 30 and 60 minutes).  
 
 
 
Figure 3.2  Lowess Smoother graph representing the correlation between the three incubation 
time periods (5, 30 and 60 minutes) and sperm viability after the incubation in PVP, 
SpermSlowTM (SS) and Sperm Washing medium (SW).  
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Statistical analysis on the interaction between incubation time periods and incubation 
mediums showed that the viability profile of the three mediums were parallel over time. There was 
no significant interaction between the time periods and incubation mediums (P = 0.532).  
Statistical analysis on the differencebetween the control (Sperm Washing medium) and two 
active mediums (PVP and SpermSlowTM) showed that there was a significant time effect on 
sperm viability. At the 30 minutes incubation period, the viability was 1.4% lower than at the 5 
minute incubation period (P = 0.035). At the 60 minutes incubation period, the viability was 4.7% 
lower than at the 5 minute incubation period (P < 0.001). PVP incubation showed a significant 
higher viability (4.5%) compared to the control (P < 0.001). SpermSlowTM viability, was however not 
significantly different from the control (P = 0.35). 
Statistical analysis on the equivalence between PVP and SpermSlowTM showed that PVP 
incubation resulted in a significantly higher (5.2%) viability outcome than SpermSlowTM (P < 0.05). 
Although these mediums‟ viability outcomes were statistically different from each other, these two 
mediums are however still clinically equivalent in terms of viability profile, since the limit of the 95% 
confidence interval falls within the chosen ±20 % equivalence margin.  
The original statistical analyses for sperm viability are available in Addendum XI.  
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3.1.2 Sperm chromatin packaging (n=90) 
Results for sperm chromatin packaging (CMA3 analysis) after incubation are presented in Figure 
3.3 and 3.4. 
 
Figure 3.3  Box-and-Whisker plot diagram indicating the CMA3 positive sperm profile after the 
incubation in PVP, SpermSlowTM (SS) and Sperm Washing medium (SW) for the 
three time periods (5, 30 and 60 minutes).  
 
 
 
Figure 3.4  Lowess Smoother graph representing the correlation between the three incubation 
time periods (5, 30 and 60 minutes) and sperm CMA3 profile after the incubation in 
PVP, SpermSlowTM (SS) and Sperm Washing medium (SW). 
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Statistical analysis on the interaction between incubation time periods and incubation 
mediums showed that the CMA3 profile of the three mediums were parallel over time. There was 
no significant interaction between the time periods and incubation mediums (P = 0.1787).  
Statistical analysis on the differencebetween the control (Sperm Washing medium) and two 
active mediums (PVP and SpermSlowTM) showed that there was no significant time effect on the 
CMA3 profile (P = 0.1515). PVP and SpermSlow
TM incubation did not differ significantly from the 
control (P = 0.073 and 0.629 respectively).  
Statistical analysis on the equivalence between PVP and SpermSlowTM showed that PVP 
incubation resulted in a significantly higher (1.2%) CMA3 outcome (less mature sperm DNA) than 
SpermSlowTM (P = 0.022). Although these mediums‟ CMA3 outcome were statistically different from 
each other, these two mediums are however still clinically equivalent in terms of CMA3 profile, 
since the limit of the 95% confidence interval falls within the chosen ±10 % equivalence margin.  
The original statistical analyses for sperm chromatin packaging are available in Addendum XI.  
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3.1.3  Sperm DNA fragmentation (n=29) 
Results for sperm DNA fragmentation (TUNEL analysis) after incubation are presented in Figure 
3.5 and 3.6. 
 
Figure 3.5  Box-and-Whisker plot diagram indicating the TUNEL positive sperm profile after the 
incubation in PVP, SpermSlowTM (SS) and Sperm Washing medium (SW) for the 
two time periods (30 and 60 minutes).  
 
 
 
Figure 3.6  Lowess Smoother graph representing the correlation between the two incubation 
time periods (30 and 60 minutes) and sperm TUNEL profile after the incubation in 
PVP, SpermSlowTM (SS) and Sperm Washing medium (SW). 
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Statistical analysis on the interaction between incubation time periods and incubation 
mediums showed that the TUNEL profile of the three mediums were parallel over time. There was 
no significant interaction between the time periods and incubation mediums (P = 0.3959).  
Statistical analysis on the differencebetween the control (Sperm Washing medium) and two 
active mediums (PVP and SpermSlowTM) showed that there was no significant time effect on the 
TUNEL profile (P = 0.794). PVP and SpermSlowTM incubation did not differ significantly from the 
control (P = 0.299 and 0.145 respectively).  
Statistical analysis on the equivalence between PVP and SpermSlowTM showed that PVP 
incubation resulted in a significantly lower (1.5%) TUNEL outcome (less fragmented sperm DNA) 
than SpermSlowTM (P = 0.021). Although these mediums‟ TUNEL outcome were statistically 
different from each other, these two mediums are however still clinically equivalent in terms of 
TUNEL profile, since the limit of the 95% confidence interval falls within the chosen ±10 % 
equivalence margin.  
The original statistical analyses for sperm DNA fragmentation are available in Addendum XI.  
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3.1.4  Sperm motility (n=90) 
Results for sperm motility (CASA) after incubation are presented in Figure 3.7 and 3.8. 
 
Figure 3.7  Box-and-Whisker plot diagram indicating sperm motility profile after the incubation in 
PVP, SpermSlowTM (SS) and Sperm Washing medium (SW) for the three time 
periods (5, 30 and 60 minutes).  
 
 
 
Figure 3.8  Lowess Smoother graph representing the correlation between the three incubation 
time periods (5, 30 and 60 minutes) and sperm motility after the incubation in PVP, 
SpermSlowTM (SS) and Sperm Washing medium (SW). 
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Statistical analysis on the interaction between incubation time periods and incubation 
mediums showed that the motility profile of the three mediums were not parallel over time. There 
was a statistically significant interaction between the incubation time periods and mediums (P = 
0.0003).  
Since there was interaction between the incubation time periods and mediums, time specific 
comparisons betweenthe control (Sperm Washing medium) and two active mediums (PVP 
and SpermSlowTM) were made. Statistical analysis showed that there was no significant difference 
in motility between PVP and control, or SpermSlowTM and control at the 5 minute incubation time 
periods (P = 0.226 and P = 0.257 respectively). However, at the 30 minute incubation period, there 
was a significant difference between PVP and control, as well as SpermSlowTM and control (both P 
< 0.001). PVP showed a significantly lower motility percentage of 3.5% than the control, while 
SpermSlowTM showed 3.0% lower motility when compared to the control. At the 60 minute 
incubation time, once again there was a significant difference between PVP and control, as well as 
SpermSlowTM and control (both P < 0.001). PVP showed a 7.1% lower motility than the control, 
while SpermSlowTM showed a 5.0% lower motility when compared with the control.  
Statistical analysis on the equivalence between PVP and SpermSlowTM showed there was no 
statistically significant difference in motility between PVP and SpermSlowTM at any of the time 
points, since all of the P-values were > 0.05. The overall difference, taking all three time points into 
account, between PVP and SpermSlowTM was 0.9% with 95% confidence interval (- 0.3% to 2.0% 
confidence interval). There was also no significant difference between the overall profiles of PVP 
and SpermSlowTM (P = 0.147). These two mediums are clinically equivalent in terms of motility 
profile, since the 95% confidence interval of the difference between PVP and SpermSlowTM falls 
within the chosen ±20 % equivalence margin.  
The original statistical analyses for sperm motility are available in Addendum XI.  
  
Stellenbosch University  https://scholar.sun.ac.za
59 
 
3.1.5  Progressive spermatozoa (n=90) 
Results for progressive spermatozoa (CASA) after incubation are presented in Figure 3.9 and 3.10. 
 
Figure 3.9  Box-and-Whisker plot diagram indicating progressive sperm profile after the 
incubation in PVP, SpermSlowTM (SS) and Sperm Washing medium (SW) for the 
three time periods (5, 30 and 60 minutes).  
 
 
 
Figure 3.10  Lowess Smoother graph representing the correlation between the three incubation 
time periods (5, 30 and 60 minutes) and progressive sperm percentage after the 
incubation in PVP, SpermSlowTM (SS) and Sperm Washing medium (SW). 
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Statistical analysis on the interaction between incubation time periods and incubation 
mediums showed that the progressive sperm profile of the three mediums were not parallel over 
time. There was a statistically significant interaction between the incubation time periods and 
mediums (P = 0.0003).  
Since there was significant interaction between the incubation time periods and mediums, time 
specific comparisons betweenthe control (Sperm Washing medium) and two active mediums 
(PVP and SpermSlowTM) were made. Statistical analysis showed that there was no significant 
difference in the progressive sperm profile between PVP and control, or SpermSlowTM and control 
at the 5 minute incubation time periods (P = 0.47 and P = 0.118 respectively). However, at the 30 
minute incubation period, there was a significant difference between PVP and control, as well as 
SpermSlowTM and control (both P < 0.001). PVP showed a significantly lower progressive sperm 
percentage of 2.3% than the control, while SpermSlowTM showed 1.8% lower progressive sperm 
when compared to the control. At the 60 minute incubation time, once again there was a significant 
difference between PVP and control, as well as SpermSlowTM and control (P < 0.001 and P = 
0.002 respectively). PVP showed 5.0% lower progressive sperm than the control, while 
SpermSlowTM showed 3.3% lower progressive sperm when compared with the control.  
Statistical analysis on the equivalence between PVP and SpermSlowTM showed there was no 
statistically significant difference in percentage progressive sperm between PVP and SpermSlowTM 
at any of the specific time points, since all of the P-values were > 0.05. However, the overall 
difference between the two mediums was 1.6% and shows that PVP has a significant higher 
percentage progressive sperm compared to SpermSlowTM (P = 0.013). Although the two mediums 
do differ statistically, they are however still clinically equivalent in terms of progressive sperm 
profile, since the 95% confidence interval of the difference between PVP and SpermSlowTM falls 
within the chosen ±20 % equivalence margin. 
The original statistical analyses for progressive sperm outcome are available in Addendum XI.  
Stellenbosch University  https://scholar.sun.ac.za
61 
 
 
 
3.1.6  Sperm motility kinetics (n=90) 
Various sperm motility kinetic parameters (VAP, VSL, BCF, VCL, STR, LIN) after incubation were 
also analysed during Experiment A using the CASA system. Since the clinical equivalence margins 
could not be set for these variables, it was decided that these CASA variables will not be 
statistically analysed. Instead, the mean values for each variable was calculated for each of the 
different incubation periods as well as the three mediums (see Figure 3.11 – 3.17).  
There was a small increase at the 30 minute incubation period which either decreased or 
plateaued at the 60 minute incubation period in all of the mediums (PVP, SpermSlowTM and Sperm 
Washing medium) for all these motility kinetic parameters (VAP, VSL, BCF, VCL, STR, LIN).  
 
 
Figure 3.11  Line graph indicating the mean sperm VAP profile after the incubation in PVP, 
SpermSlowTM (SS) and Sperm Washing medium (SW) for the three time periods (5, 
30 and 60 minutes).  
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Figure 3.12  Line graph indicating the mean sperm VSL profile after the incubation in PVP, 
SpermSlowTM (SS) and Sperm Washing medium (SW) for the three time periods (5, 
30 and 60 minutes).  
 
 
 
 
 
Figure 3.13  Line graph indicating the mean sperm VCL profile after the incubation in PVP, 
SpermSlowTM (SS) and Sperm Washing medium (SW) for the three time periods (5, 
30 and 60 minutes).  
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Figure 3.14 Line graph indicating the mean sperm ALH profile after the incubation in PVP, 
SpermSlowTM (SS) and Sperm Washing medium (SW) for the three time periods (5, 
30 and 60 minutes).  
 
 
 
 
 
Figure 3.15 Line graph indicating the mean sperm BCF profile after the incubation in PVP, 
SpermSlowTM (SS) and Sperm Washing medium (SW) for the three time periods (5, 
30 and 60 minutes).  
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Figure 3.16 Line graph indicating the mean sperm STR profile after the incubation in PVP, 
SpermSlowTM (SS) and Sperm Washing medium (SW) for the three time periods (5, 
30 and 60 minutes).  
 
 
 
 
Figure 3.17  Line graph indicating the mean sperm LIN profile after the incubation in PVP, 
SpermSlowTM (SS) and Sperm Washing medium (SW) for the three time periods (5, 
30 and 60 minutes).  
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3.2 Secondary objective: The effect of PVP and SpermSlowTM on human sperm 
ultrastructure (Transmission electron microscopy) (n=1) 
 
Unfortunately due to the high cost of the transmission electron microscopy analysis, only one 
sample‟s micrographs were evaluated. The results of this analysis are presented in Table 3.3. 
Micrographs with classification annotations are presented in Figure 3.18 – 3.20.  
 
 
Table 3.3 The effect of the three mediums (PVP, SpermSlowTM and Sperm Washing medium) 
on sperm ultrastructure after one hour incubation time.  
Sperm characteristics PVP SS SW 
PVP vs 
SS 
PVP vs 
SW 
SS vs 
SW 
P-value P-value P-value 
Cytoplasmic 
membrane  
Neck-
piece 
Conserved 
62/73 
(84.9) 
73/111 
(65.8) 
32/36 
(88.9) 
0.004 0.573 0.008 
Ruptured 
11/73 
(15.1) 
38/111 
(34.2) 
4/36 
(11.1) 
0.004 0.573 0.008 
Mid-piece 
Conserved 0 0 
4/14 
(28.6) 
- - - 
Not well defined 
10/10 
(100) 
39/39 
(100) 
10/14 
(71.4) 
- 0.064 0.001 
Acrosomal 
vesicle  
Acrosomal 
vesicle 
Well attached to 
the nucleus  
20/138 
(14.5) 
5/221  
(2.3) 
12/105 
(11.4) 
<0.001 0.484 0.001 
Abnormal 
118/138 
(85.5) 
216/221 
(97.7) 
93/105 
(88.6) 
<0.001 0.484 0.001 
Presence 
Short-absent / 
Amorphous-
reacted / not totally 
defined  
87/138 
(63.0) 
200/221 
(90.5) 
68/105 
(64.8) 
<0.001 0.782 <0.001 
Position 
Partially detached / 
Totally detached  
31/138 
(22.5) 
16/221  
(7.2) 
25/105 
(23.8) 
<0.001 0.805 <0.001 
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Nucleus  Shape 
Normal 
9/138 
(6.5) 
10/221  
(4.5) 
12/105 
(11.4) 
0.411 0.177 0.02 
Abnormal 
129/138 
(93.5) 
211/221 
(95.5) 
93/105 
(88.6) 
0.411 0.177 0.02 
 
Content  
Dense 
100/138 
(72.5) 
182/221 
(82.4) 
104/105 
(99.0) 
0.026 <0.001 <0.001 
Not dense 
38/138 
(27.5) 
39/221 
(17.6) 
1/105  
(1.0) 
0.026 <0.001 <0.001 
Pale areas 
Small nuclear 
space (also called 
nuclear vacuoles) 
90/138 
(65.2) 
132/221 
(59.7) 
84/105  
(80) 
0.298 0.011 <0.001 
Large pale areas  
48/138 
(34.8) 
89/221 
(40.3) 
21/105  
(20) 
0.298 0.011 <0.001 
Neck-piece / 
mid-piece 
Basal plate Normal Normal Normal - - - 
Striated columns Normal Normal Normal - - - 
Outer dense fibre Normal Normal Normal - - - 
Mitochondrial 
helix 
Regular helix, moderate dense 
with small pale areas 
29/62  
(46.8) 
45/87  
(51.7) 
14/25  
(56) 
0.551 0.436 0.706 
Enlarged and pale (swollen) / 
Displaced not forming a helix 
33/62  
(53.2) 
42/87  
(48.3) 
11/25  
(44) 
0.551 0.436 0.706 
Axoneme-
principal 
piece 
9d + 2s 
Normal pattern 
11/61  
(18.0) 
0 
17/27  
(63.0) 
- <0.001 - 
Abnormal pattern / 
Absence, reduced 
or displaced 
number of 
doubled, nexin 
links, dynein arms, 
radial spokes, 
central pair 
50/61  
(82.0) 
23/23  
(100) 
10/27  
(37) 
0.029 <0.001 <0.001 
Annulus Normal Normal Normal - - - 
Outer dense fibre Normal Normal Normal - - - 
Fibrous sheath  Normal Normal Normal - - - 
Values in brackets are the value expressed in percentage   
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Micrographs were taken with at least 10 000x magnification and sperm characteristics were 
identified and annotated. 73 neck-piece cytoplasmic membranes were identified and evaluated in 
the PVP exposed spermatozoa micrographs. 84.9% of these were conserved and 15.1% were 
ruptured. 111 neck-piece cytoplasmic membranes were identified and evaluated in the 
SpermSlowTM exposed spermatozoa micrographs. 65.8% of these were conserved and 34.2% 
were ruptured. Only 36 neck-piece cytoplasmic membranes were identified and evaluated in the 
control group‟s micrographs. 88.9% of these were conserved and 11.1% were ruptured.  
The sperm cytoplasmic membrane was evaluated by examining both the neck-piece and mid-
piece sperm characteristics. The neck-piece characteristics showed no significant difference (P > 
0.05) between PVP exposed spermatozoa and the control (Sperm Washing medium). 
SpermSlowTM incubated spermatozoa showed significantly lower conserved and significantly 
higher ruptured neck-piece cytoplasmic membranes when compared to both PVP incubated 
spermatozoa (P < 0.05) and the control (P < 0.05). The mid-piece cytoplasmic membranes showed 
no difference between PVP and SpermSlowTM incubated spermatozoa. There were significantly 
higher less defined mid-piece cytoplasmic membrane characteristics in the SpermSlowTM group 
compared to the control (P < 0.01). 
The acrosomal vesicle sperm characteristics were evaluated by examining the vesicle‟s 
attachment to the nucleus, the presence as well as the position of the vesicle. The attachment as 
well as the presence and position characteristics showed no significant difference between PVP 
incubated spermatozoa and the control (P > 0.05). SpermSlowTM incubated spermatozoa showed 
significant lower well attached acrosomal vesicles, lower partially/totally detached acrosome 
vesicles and higher abnormal acrosomal vesicle sperm characteristics compared to both PVP and 
the control (P < 0.001).  
The sperm nucleus characteristics were evaluated by examining its shape, content and pale 
areas. PVP exposed spermatozoa showed no significant different nucleus shape characteristics 
Stellenbosch University  https://scholar.sun.ac.za
68 
 
compared to both SpermSlowTM and the control (P > 0.05). There were significantly less normal 
shaped nuclei in the SpermSlowTM group compared to the control (P < 0.05). The nucleus content 
density differed for each medium (P < 0.05). Sperm Washing medium (control) showed the best 
density, followed by SpermSlowTM exposed spermatozoa and then PVP exposed spermatozoa. 
PVP compared to SpermSlowTM incubated spermatozoa showed no significant difference in the 
nucleus pale area sperm characteristics (large pale areas and nuclear vacuoles). However, both 
SpermSlowTM and PVP groups were significantly different (P < 0.05) when compared to the control 
for nuclear vacuoles and large pale areas.  
No significant differences were observed in the mitochondrial helix sperm characteristics 
between groups.  
The axoneme-principal piece sperm characteristics were evaluated by examining the 9d + 2s 
pattern, annulus, outer dense fibre and fibrous sheath. Both PVP and SpermSlowTM exposed 
spermatozoa showed significant lower 9d + 2s normal pattern sperm characteristics when 
compared to the control (P < 0.001).  
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NP  : neck-piece 
NPm : intact neck-piece 
NPm-* : ruptured neck-piece membrane 
MP : mid-piece 
MPm-* : ruptured mid-piece 
PP : principal-piece 
PPm-* : ruptured principal-piece 
N 
: dense nuclear density 
: abnormal nucleus shape 
NS-* : large pale nuclear spaces 
AV : intact acrosomal vesicle 
AV-* 
: short-absent-amorphous-not 
totally defined acrosomal vesicle 
mi : mitochondrial helix 
mi-* 
: enlarged, swollen or displaced 
mitochondrial helix  
BP : normal basal plate 
Ce : normal centriole  
SC : normal striated columns 
ODF : normal outer dense fibres  
An : normal annulus 
FS : normal fibrous sheath  
Figure 3.18  Transmission electron microscopy (TEM) micrograph with classification 
annotations of Sperm Washing medium (control) incubated spermatozoa. 
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NPm : intact neck-piece 
NPm-* : ruptured neck-piece membrane 
MPm : intact mid-piece 
N : dense nuclear density 
N-* 
: decondensed nuclear density 
: abnormal nucleus shape 
NS-* : large pale nuclear spaces 
AV : intact acrosomal vesicle 
AV-* 
: short-absent-amorphous-not 
totally defined acrosomal vesicle 
mi : mitochondrial helix 
Ax : normal 9d+2s axoneme pattern 
Figure 3.19  TEM micrograph with classification annotations of PVP incubated spermatozoa.  
 
 
NPm : intact neck-piece 
NPm-* : ruptured neck-piece membrane 
MPm-* : ruptured mid-piece 
PPm-* : ruptured principal-piece 
N : dense nuclear density 
N-* : decondensed nuclear density 
NN : normal nucleus shape 
NS-* : large pale nuclear spaces 
AV : intact acrosomal vesicle 
AV-* 
: short-absent-amorphous-not 
totally defined acrosomal vesicle 
mi : mitochondrial helix 
mi-* 
: enlarged, swollen or displaced 
mitochondrial helix  
Ax-* abnormal axoneme pattern  
Figure 3.20  TEM micrograph with classification annotations of SpermSlowTM incubated 
spermatozoa. 
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CHAPTER 4 
Discussion and Conclusion  
 
IMSI is seen as one of the techniques available to treat patients where the male partner presents 
with an elevated sperm DNA fragmentation rate. This modified ICSI technique allows 
embryologists to identify subtle sperm morphology features and requires a high level of technical 
expertise and inter-observer reproducibility. Hamilton Thorne IVOS® developed a software solution 
(IMSI StrictTM) for sperm morphology categorization and IMSI sperm selection. This software aims 
to enable objective classification of spermatozoa, eliminating inter-technician variation. 
For good optics and spermatozoon evaluation and selection in IMSI StrictTM, spermatozoa need to 
be moving very slowly or be immotile, but still viable. This can be achieved by incubating prepared 
spermatozoa in a viscous holding medium, either PVP or SpermSlowTM medium, for the duration of 
the selection period. Before marketing the clinical use of IMSI StrictTM, the possible toxicity or 
deleterious effect of these holding mediums on basic semen parameters, as well as sperm DNA 
and structural integrity of spermatozoa, need to be excluded.  
In this study the effect of PVP and SpermSlowTM on human spermatozoa‟s viability (n=90), motility 
parameters (n=90), chromatin packaging (n=90), DNA fragmentation (n=29) and ultrastructure 
(n=1) was evaluated. All semen samples were prepared with a routine swim up method, since this 
represents the type of sample used during IMSI. Prepared, motile sperm samples were incubated 
for three time periods in PVP, SpermSlowTM and Sperm Washing medium (control).  
Statistical analyses with P-values of <0.05 were considered statistically significant. However, 
whether or not PVP and SpermSlowTM,s data sets were equivalent had to be established. The 
conventional significant test has little relevance in an equivalence trial. A failure to detect a 
difference does not imply equivalence (Altman et al., 1995). On the other hand, a detected 
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difference may not have any clinical relevance and may correspond to practical equivalence. The 
confidence interval defines a range for the possible true difference between two treatments. If 
every confidence interval point within this range corresponds to a difference of no clinical 
importance, then only may the treatment be considered to be equivalent. Therefore, a range of 
equivalence had to be predefined and then it could be established whether the confidence interval 
(centred on the observed difference) lies within these set margins (Jones et al., 1996). Senior 
scientists in the reproductive biology field were approached to establish an equivalence margin for 
all the variables tested. Using the equivalence margins, it was possible to establish whether or not 
PVP and SpermSlowTM were clinically equivalent. The equivalence margins for sperm viability, 
motility and percentage progressive spermatozoa were set at ±20%. The equivalence margins for 
both CMA3 and TUNEL positive parameters were set at ±10%.  
To our knowledge, this is the first study that compared the effect of PVP and SpermSlowTM on 
human spermatozoa‟s viability, motility parameters and chromatin packaging profiles. Therefore, 
we could not compare our results to any other published studies.  
The interaction between the incubation time and the tested mediums showed that the sperm 
viability profile of the three mediums were parallel over time. There was no significant interaction 
between the incubation time and the tested mediums for the sperm viability outcome and, hence, 
the effect of PVP or SpermSlowTM on sperm viability was independent of the length of exposure 
time. The outcome of the specific comparison between the two active mediums (PVP and 
SpermSlowTM) and the control (Sperm Washing medium) indicated that there was a significant time 
effect on sperm viability. Sperm viability significantly decreased over time, with the 60 minute 
incubation time period resulting in the lowest viability, as could be expected. PVP incubated 
spermatozoa showed a significant higher viability when compared to the control. SpermSlowTM on 
the other hand, did not differ significantly from the control with regards to viability. Furthermore, 
PVP incubated spermatozoa showed a statistically significant higher viability when compared to 
SpermSlowTM incubated spermatozoa. However, this viability difference was only 5.2% and not of 
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any clinical significance. The reason for the better performance of PVP regarding sperm viability is 
difficult to explain.  
The interaction between the incubation time and tested mediums showed that the CASAmotility 
and percentage progressive sperm profiles of the three mediums differed over time. There was a 
significant interaction between the incubation time and the tested mediums for the CASA motility 
and progressive sperm outcomes and, hence, the effect of PVP or SpermSlowTM on sperm motility 
outcomes was dependent of the length of exposure time. The outcome of the specific comparison 
between the active mediums (PVP and SpermSlowTM) and the control (Sperm Washing medium) 
indicated that PVP as well as SpermSlowTM incubation showed a significant lower motile and 
percentage progressive spermatozoa at the 30 and 60 minute incubation time periods compared to 
the control. There was a negative correlation between incubation time and the two motility 
parameters. The longer the incubation time, the more the motility and progressive sperm 
percentages decreased, as could be expected. Although all test sperm solutions were washed and 
resuspended in Sperm Washing medium before CASA motility analyses, we speculate that this 
decrease in motility and percentage progressive sperm parameters are due to the fact that the PVP 
and SpermSlowTM medium are viscous. The sperm energy mechanism may be depleted during the 
attempt of the spermatozoa to move in this medium, which may lead to the decrease in motility and 
percentage progressive sperm after a prolonged incubation period. The outcome of the specific 
comparison between PVP and SpermSlowTM was analysed in order to evaluate the equivalence of 
the two mediums. No statistically significant difference between the overall motility profiles of PVP 
and SpermSlowTM incubated spermatozoa was observed. PVP did however show a statistically 
significant higher overall progressive sperm profile compared to SpermSlowTM. However, 
thisprogressive sperm difference was only 1.6% and not of any clinical significance. The reason for 
the better performance of PVP regarding progressive sperm outcome is difficult to explain. 
Since the clinical equivalence margins could not be set for the different CASA sperm motility 
kinetics (VAP, VSL, BCF, VCL, STR, LIN), these variables were not statistically analysed. The 
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mean value for each variable was calculated for each of the different incubation periods as well as 
the three mediums. These results showed a small increase at the 30 minute incubation period 
which either decreased or plateaued at the 60 minute incubation period in all three mediums for all 
of these motility kinetics (VAP, VSL, BCF, VCL, STR, LIN). Therefore, PVP and SpermSlowTM 
medium were clinically equivalent with regards to its effect on sperm motility kinetics.  
The interaction between the incubation time and mediums showed that the sperm chromatin 
packaging profile (CMA3 analysis) of the three mediums were parallel over time. There was no 
significant interaction between the incubation time and the tested mediums for the CMA3 outcome 
and, hence, the effect of PVP or SpermSlowTM on sperm chromatin packaging was independent of 
the length of exposure time. The outcome of the specific comparison between the two active 
mediums (PVP and SpermSlowTM) and the control (Sperm Washing medium) indicated that neither 
PVP nor SpermSlowTM incubation showed a significant difference in chromatin packaging when 
compared to the control. Furthermore, PVP showed a statistically significant higher CMA3 outcome 
than SpermSlowTM when the outcome of the specific comparison between PVP and SpermSlowTM 
was analysed. This indicates that PVP incubation resulted in less mature sperm chromatin 
packaging comparing to SpermSlowTM. However, this CMA3difference was only 1.2% and not of 
any clinical significance. The reason for the better performance of SpermSlowTM regarding sperm 
chromatin packaging outcome is difficult to explain. 
To our knowledge, only two previous, similar studies compared the effect of PVP and 
SpermSlowTM on human spermatozoa‟s DNA fragmentation (Salian et al., 2012, Rougier et al., 
2013). Therefore, we were able to compare our results with their findings. 
The interaction between the incubation time and mediums showed that the sperm DNA 
fragmentation profile (TUNEL analysis) of the three mediums were parallel over time. There was 
no significant interaction between the incubation time and the tested mediums for the TUNEL 
outcome and, hence, the effect of PVP or SpermSlowTM on sperm DNA fragmentation was 
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independent of the length of exposure time. The outcome of the specific comparison between the 
two active mediums (PVP and SpermSlowTM) and the control (Sperm Washing medium) indicated 
that neither PVP nor SpermSlowTM incubated spermatozoa showed a significant difference in DNA 
fragmentation when compared to the control. Furthermore, PVP incubation did result in a 
statistically significant lower TUNEL outcome specifically compared to the SpermSlowTM outcome. 
This indicates that PVP incubation results in less sperm DNA fragments comparing to 
SpermSlowTM. However, thisTUNELdifference was only 1.5% and not of any clinical significance. 
Salian et al. (2012) compared the effect of PVP and SpermSlowTM incubation on the DNA integrity 
of fresh and frozen-thawed spermatozoa during conventional ICSI conditions from 
normozoospermic and oligozoospermic ejaculates. Prepared spermatozoa (after a routine swim up 
technique) were incubated for 30 minutes and assessed for sperm DNA fragmentation using a 
single-cell gel electrophoresis assay. They observed a detrimental effect of PVP medium on sperm 
DNA of oligozoospermic semen samples and a further increase in sperm DNA fragmentation when 
frozen-thawed spermatozoa from both normozoo- and oligozoospermic semen samples were 
exposed to PVP. However, SpermSlowTM did not notably induce DNA fragmentation in any of the 
tested groups. Their results differed from our study. We observed no significant difference in DNA 
fragmentation (TUNEL analysis) when PVP exposed spermatozoa were compared to the control 
(Sperm Washing medium). However, similar to Salian et al.‟s study, SpermSlowTM exposed 
spermatozoa also showed no significant increased DNA fragmentation when compared to the 
control. When comparing PVP specifically with SpermSlowTM exposed spermatozoa, the only 
significant difference Salian et al. reported was sperm DNA fragmentation observed in the 
oligozoospermic frozen-thawed samples. They observed a significant higher extent of DNA 
fragmentation in the PVP group compared to the SpermSlowTM group. Again the results from our 
study differ from this result, since we found a significant lower (1.5%) extent of DNA fragmentation 
in the PVP group compared to the SpermSlowTM group. Although this 1.5% difference was 
statistically significant, we concluded after equivalence statistical analysis that clinically the 
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difference was not significant and that the induction of sperm DNA fragmentation by either PVP or 
SpermSlowTM is equivalent. The reason for the difference in results could possibly be explained by 
the fact that different sperm DNA fragmentation tests were used.  
Rougier et al. (2013) compared the changes in sperm DNA fragmentation after incubating prepared 
spermatozoa (after a routine double-layer gradient) in PVP and SpermSlowTM for different time 
periods. They used TUNEL staining for the sperm DNA fragmentation evaluation and divided the 
sample population into two groups; original semen samples with <20% or ≥20% positive TUNEL 
evaluation. They found a more rapid DNA damage increase over time in samples with ≥20% DNA 
fragmentation than samples with <20% DNA fragmentation. However, PVP and SpermSlowTM 
incubation had similar effects and did not differ significantly. Once again, although our study 
showed a statistically significant, but small (1.5%) decreased DNA fragmentation outcome in the 
PVP group compared to the SpermSlowTM group, clinically this difference was not significant. We 
agree with Rougier et al.‟s findings and conclude that clinically PVP and SpermSlowTM show 
equivalent DNA fragmentation in spermatozoa when incubated for different time periods.  
Another study that also investigated the effect of PVP was that of Ray et al. (1995). They tested the 
effect of PVP on cultured human somatic cells that acted as a model to investigate the mutagenic 
potential of PVP by sister chromatid exchange analysis prior to use in intracytoplasmic sperm 
injection procedures. They found that PVP do not cause DNA lesions resulting insisterchromatid 
exchanges.  
As a secondary objective the effect of PVP and SpermSlowTM on human spermatozoa’s 
ultrastructure was evaluated using Transmission Electron Microscopy (TEM).  
The outcome of the specific comparison between the three mediums (PVP, SpermSlowTM and 
Sperm Washing medium) was analysed. The sperm characteristics negatively affected by PVP 
incubation were the nucleus density, presence of large nuclear pale areas, as well as the 9d + 2s 
pattern of the axoneme principal piece. The sperm characteristics negatively affected by 
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SpermSlowTM incubation included the cytoplasmic membrane of the neck-piece and mid-piece, 
most acrosomal features, most nucleus features as well as the 9d + 2s pattern of the axoneme 
principal piece. The only sperm characteristics not influenced by SpermSlowTM were the 
mitochondrial helix features. However, these features were also not affected by PVP. Interestingly 
the SpermSlowTM exposed sperm group showed the lowest amount of partially detached or totally 
detached acrosomal vesicles when compared to PVP and Sperm Washing medium exposed 
spermatozoa. SpermSlowTM incubated spermatozoa also showed no significant difference in the 
amount of nuclear vacuoles when compared to the PVP group. Furthermore, the Sperm Washing 
medium group showed the highest amount of nuclear vacuoles between the three groups.  
Only one previous study by Strehler et al. (1998) evaluated the effect of PVP medium on the 
ultrastructure of human spermatozoa. They found that the sperm characteristics negatively affected 
by PVP included the acrosomal features (position, shape, dimension, content and presence of 
reacted acrosomes), some nuclear features (shape, condensation and presence of disrupted 
chromatin), mitochondria features (shape and helix assembly), some general features of the 
axoneme (9d + 2s pattern, accessory fibres and fibrous sheath) as well as plasma membrane 
integrity. It was concluded that PVP incubation led to the disintegration of various sperm 
membranes that caused the alteration of chromatin and cytoskeletal components.  
It is clear that PVP treatment did not nearly affect the ultrastructure of spermatozoa to the same 
extend in our study as reported by Strehler et al. (1998). The reason for the difference in results 
could be explained by the fact that only one semen sample was analysed in our study, while 
Strehler andcolleagues analysed a total of 12 semen samples. Another possible reason can be the 
fact that the sperm population used for these studies differed. Strehler et al. only washed the 
semen samples before PVP incubation, while we did a routine swim up on the semen sample 
before PVP and SpermSlowTM incubation. We also do not know whether our results represent the 
total „health‟ of the sperm population, since the number of spermatozoa analysed for each of the 
sperm characteristics, varied extensively.  
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Although not similar to our study, De Leeuw et al. (1993) found that the addition of PVP to 
cryoprotective agents significantly reduced bull sperm membrane integrity after cooling and 
freezing. Dozortsev et al. (1995b) also found that PVP possibly impede sperm nucleus 
decondensation. In contrast, our study found that PVP exposed spermatozoa expressed 
significantly less dense nucleus content than the control (Sperm Washing medium).  
According to our knowledge, this was the first study that compared the effect of PVP and 
SpermSlowTM on the ultrastructure of human spermatozoa. We found that PVP incubation 
(compared to the control) only showed significant differences regarding disrupted sperm for a few 
sperm components, while SpermSlowTM exposure led to most sperm components being 
deteriorated (compared to the control). The acrosome, plasma membrane and axoneme 
characteristics, together with the nucleus, whose condensation was affected, were shown to be the 
most affected sperm components. It is thought that since SpermSlowTM mainly consists of 
Hyaluronic acid (HA), spermatozoa bind to this molecule with HA-receptors located on the sperm 
surface. We speculate that this physiologic reaction may cause sperm membrane destabilization 
that may lead to sperm membrane breakdown. Membrane breakdowns together with necrotic 
processes may lead to nuclear deterioration. The deterioration of the axonemal tubules can also be 
explained as a consequence of the membrane disintegration.  
Based on this study‟s results, either PVP or SpermSlowTM can be used for IMSI StrictTM purposes. 
However, the study did not include the technical aspects of the usage of PVP and SpermSlowTM. In 
the SpermSlowTM instruction manual it is stated that “SpermSlowTM is not a general immobilising 
agent (such as PVP); therefore it has quite different characteristics”. Comparing the different 
specifications, shelf life, incubation requirements, cost and ease of use of the two holding solutions 
(Addendum XII), PVP seems to have better properties than SpermSlowTM. PVP‟s self-life is four 
times longer than SpermSlowTM and SpermSlowTM is almost three times more expensive than PVP. 
However, it is important to take into account that our study did not test SpermSlowTM‟s ability to 
improve non-fragmented sperm DNA selection. Since SpermSlowTM allows the active selection of 
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mature spermatozoa when performing ICSI (Parmegiani et al., 2010a) and PVP does not, it can be 
argued that SpermSlowTM will theoretically be the more obvious choice between the two mediums 
for IMSI strictTM. Using SpermSlowTM will allow the easy application of physiologic IMSI, where 
spermatozoa can first be selected based on their maturity (ability to bind onto SpermSlowTM‟s HA) 
and then be selected based on their morphological appearance.  
Although this study did not include any ART procedures, Parmegiani et al. (2010a) conducted a 
study comparing SpermSlowTM-ICSI and PVP-ICSI outcomes. A statistical significant improvement 
in embryo quality and development were observed when oocytes were injected with SpermSlowTM-
selected spermatozoa compared to PVP-ICSI. A trend towards better fertilization, pregnancy and 
implantations in the SpermSlowTM-ICSI group was observed, however, these findings were not 
significant. With a large retrospective comparison of SpermSlowTM-ICSI versus conventional PVP-
ICSI, Parmegiani et al. (2010b) confirmed their initial observation. They reported a trend towards 
better fertilization, pregnancy and abortion rates in the SpermSlowTM-ICSI group. Furthermore, 
injection of SpermSlowTM-bound spermatozoa significantly improved embryo quality and 
implantation rates. In contrast, some authors found no statistically significant differences in 
fertilization rates, embryo quality, pregnancy rates or implantation rates when comparing 
SpermSlowTM-ICSI with conventional PVP-ICSI treatments (Van Den Berg et al., 2009; Ménézo et 
al., 2010).  
Various limitations and recommendations for future research can be identified. We did not establish 
the inter- and intra-technician variation for the different sperm parameters tested. Only 29 samples 
were used for the TUNEL analysis compared to 90 test samples for the sperm viability, motility and 
CMA3 analysis. The TUNEL analysis also did not include the 5 minute incubation samples for the 
29 test samples. As previously mentioned, only one sample was used for the transmission electron 
microscopy (TEM) evaluation. This was due to a lack of expertise (evaluation was outsourced to an 
expert) and funding. Future studies can be improved by including inter- and intra-technician 
variation for the different sperm parameters tested, analysing more samples with the TUNEL 
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evaluation, as well as including more TEM analyses. We also recommend that the technical 
application of PVP and SpermSlowTM in the IMSI StrictTM technique should be investigated before a 
final recommendation can be made.  
From these findings we conclude that although PVP and SpermSlowTM incubated sperm outcomes 
often differed significantly after statistical analysis, clinically these two mediums were shown to be 
equivalent for the tested outcomes. These mediums also did not have a clinical detrimental effect 
on sperm viability, motility parameters, chromatin packaging and DNA fragmentation rate, as seen 
when compared to the control (Sperm Washing medium). The hypothesis that PVP and 
SpermSlowTM medium will perform the same in all the tested outcomes can be accepted.  
The secondary investigation indicated that SpermSlowTM primarily exerted a disintegrating effect on 
various sperm membranes, and as a secondary consequence of the eventual necrotic process, 
alteration of chromatin and cytoskeletal components. PVP medium on the other hand did not show 
these disintegrating effects. The hypothesis that SpermSlowTM will not be detrimental to sperm 
ultrastructure can be rejected, although with caution until more samples have been analysed.  
The difference in methodology (including semen preparation method), analyses (DNA 
fragmentation analysis method), sample size and sample type (gamete or somatic cells and human 
or animal spermatozoa) are some of the possible explanations why our study differed from findings 
of other authors.  
Since there remain many uncertainties and controversies regarding the effect of PVP and 
SpermSlowTM on human spermatozoa in the literature, we suggest that more investigations on the 
effect of PVP medium on human spermatozoa are needed. Moreover, we also suggest that the 
effect of SpermSlowTM on human spermatozoa needs further investigation.  
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CHAPTER 5 
Addenda 
 
ADDENDUM I Computer assisted semen analysis (CASA) - Motion parameters  
   (fromIVOS HT-CASA Software Manual, Version 1.1) 
 
Table 5.1 Motion parameters and their definitions measured by CASA.   
Data 
fields 
Unit 
Short 
description 
Function 
VAP µm/s 
Average path 
velocity 
The average path is determined by smoothing the sperm 
head position in a running average. The resultant path length 
is determined and divided by the elapsed time.  
VSL µm/s 
Straight line 
velocity 
The distance between the first and last points on the sperm 
track, divided by the elapsed time. 
VCL µm/s 
Curvilinear 
velocity 
VCL is measured by summing the distance between the 
sperm head positions in each frame, divided by the elapsed 
time.  
ALH µm 
Amplitude of 
lateral head 
displacement 
The maximum value of the approximately sinusoidal 
oscillation of the sperm head about the track. It is measured 
as the maximum distance between the actual sperm position 
and the corresponding average sperm position for all points 
over the track.  
BCF Hz 
Beat-cross 
frequency  
The frequency with which the sperm head crosses the 
average path line during acquisition.   
LIN % Linearity  
The ratio VSL/VCL in percent and is a measure of track 
direction.  
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STR % Straightness 
The ratio VSL/VAP in percent and is a measure of track 
compactness.  
 
 
 
 
Figure 5.1 Illustration of different motion parameters measured by the CASA system.  
(Available in: WHO; 2010)  
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ADDENDUM II Routine semen analysis (WHO, 2010 used as guideline) 
 
Semen viscosity 
After liquefaction, the viscosity of the sample was estimated. A wide-bore (approximately 1.5mm 
diameter) plastic disposable pipette was used. Semen was gently aspirated into the pipette and 
allowed to drop by gravity. The length of the thread was observed. A normal sample left the pipette 
in small discrete drops. If viscosity was abnormal, the drop formed a thread more than 2cm long. 
 
Semen volume 
The volume of the ejaculate is contributed mainly by the seminal vesicles and prostate gland, with 
a small amount from the bulbourethral glands and epididymis. Precise measurement of volume is 
essential in any evaluation of semen. It allows the total number of spermatozoa and non-sperm 
cells in the ejaculate to be calculated. The volume was measured directly from an equilibrated test 
tube (in millimetres). 
 
Semen pH 
Semen pH reflects the balance between the pH values of the different accessory gland secretions. 
These include mainly the alkaline seminal vesicle secretion and the acidic prostatic secretion. The 
pH was measured after liquefaction within one hour of ejaculation. A drop of semen was spread 
onto a pH paper. The colour was compared with the calibration strip to read the pH.  
 
Wet preparation 
One drop of semen (10μl) was placed onto a clean glass slide and covered with a coverslip (22mm 
× 22mm). The weight of the coverslip spread the sample evenly. Using a regular light microscope 
at a 400x magnification, the freshly made wet preparation was assessed as soon as the contents 
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settled under the coverslip. Motility, forward progression and other cell parameters were evaluated 
using the wet preparation.  
 
Motility 
In determining quantitative motility, the percentage of motile spermatozoa from the percentage of 
immotile spermatozoa was distinguished. The estimation of the percentage motile spermatozoa 
was made to the nearest 10%.  
 
Forward progression 
In determining qualitative motility, in our laboratory, the nature of the motility was evaluated on a 
scale of 0 to 4. 
0 No movement 
1 Movement (twitching) - none forward 
1+ Movement - every now and then 
2 Movement - undirected and slow 
2+ Movement - slowly but directly forward 
3- Movement - fast but not direct 
3 Movement - fast and direct 
3+ Movement - very fast and direct 
4 Movement - extremely fast and direct 
 
Cells 
Somatic cells (leukocytes, histiocytes and epithelium cells) were observed and expressed as 
follow:  
± A few cells on the slide 
+ 1 – 5 cells per high power field 
++ 6 – 10 cells per high power field 
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+++ >10 cells per high power field  
 
Sperm concentration 
The wet preparation was used to determine the appropriate dilution necessary for the sperm 
concentration assessment. Either 10 or 100 time dilutions were made with water. The diluted 
sample was loaded on a coverslip covered Neubauer haemocytometer, kept in a moist chamber 
and the sperm concentration assessed 10 minutes after loading. The total number spermatozoa in 
32 blocks were counted and the sperm concentration was calculated using a formula based on the 
dilution used.  
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ADDENDUM III Routine swim up sperm preparation method (modified from Tygerberg  
   Hospital Andrology manual) 
 
 
1) Allow the semen sample to liquefy.  
2) Make a wet preparation and determine the sperm parameters (estimated concentration, 
motility and forward progression).  
3) Dilute 1.5ml semen with 2ml sperm washing medium in a test tube and centrifuge at 450g 
for 10 minutes.  
4) Remove the supernatant, resuspend the remaining pellet in 2ml sperm washing medium 
and centrifuge at 450g for 10 minutes.  
5) Remove the supernatant and carefully overlay the pellet with 1ml sperm washing medium.  
6) Incubate the tube at an angled position at 37°C for one hour to ensure a maximum area for 
the sperm to swim into.  
7) After the one hour incubation period, aspirate 1ml of the top medium that contains the 
motile sperm with a pipette and place into a clean and well labelled test tube.  
8) Prepare a wet preparation slide and determine the sperm parameters (estimated 
concentration, motility and forward progression).  
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ADDENDUMIV Diagrammatic presentation of methodology 
Routine swim-up
Semen
[quantitative analysis: n=90]
[descriptive analysis: n=1]
Sperm wash 
treatment (control)
60 minutes
Wash and 
resuspend
(C3) 
30 minutes
Wash and 
resuspend
(C2) 
5 minutes
Wash and 
resuspend
(C1) 
SpermSlowTM
treatment
60 minutes
Wash and 
resuspend
(S3) 
30 minutes
Wash and 
resuspend
(S2) 
5 minutes
Wash and 
resuspend
(S1) 
PVP treatment
60 minutes
Wash and 
resuspend
(P3) 
30 minutes
Wash and 
resuspend
(P2) 
5 minutes
Wash and 
resuspend
(P1) 
Quantitative analysis [Experiment A]: CASA Motility analysis 
Viability Stain analysis 
CMA3 staining analysis 
TUNEL analysis 
Descriptive analysis [Experiment B]:  Transmission Electron Microscopy (TEM) analysis 
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ADDENDUM V Computer assisted semen analysis (CASA) - Motility and Kinematics 
analysis method (from IVOS HT-CASA Software Manual, Version 1.1) 
Figure 5.2 Photograph of a Leja® loading chamber used for CASA motility analysis. 
(Photo by M Nel) 
Method: 
1) Load ±5µl of the well mixed sperm solutions (after resuspension) into both 20µm
deepchambers of a Leja® slide (see Figure 5.2).
2) Allow the solution to spread by capillary action.
3) Set the CASA machine (IVOS® Hamilton Thorne CASA system equipped with HT-CASA II
software version 1.1) up for sperm motility evaluation according to the software manual.
4) Place the slide into the loading chamber. Use the LOAD, JOG IN and JOD OUT buttons to
ensure that the slide is in the correct position for the analysis.
5) Use the focus knob to adjust the focus and analyse the sperm motility and motion parameters
using the STANDARD HUMAN MOTILITY setup. (Use the software manual where needed)
6) Assess 6 fields per chamber (12 fields in total). The tracks of at least 200 motile spermatozoa
per specimen should be counted. 
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ADDENDUM VI Eosin-Nigrosin vital staining method (modified from WHO, 2010) 
 
1) Mix the test sperm solution well.  
2) Use the porcelain spot plate and mix 10µl of the well mixed sperm solution with 10µl 
eosin for 15 seconds.  
3) Add 10µl nigrosin and mix for another 15 seconds.  
4) Make a smear by applying a drop of the mixed solution to the end of a labelled frosted 
glass slide. Use a second glass slide to pull the drop along the surface of the slide as 
shown in Figure 5.3. Allow the smear to air dry.  
 
Figure 5.3 Schematic representation of the semen smearing method 
(Available in: WHO, 2010) 
 
5) Examine each slide with bright field optics at ×1000 magnification and oil immersion. 
6) Evaluate one hundred spermatozoa on each slide (using a laboratory counter) and 
annotate the percentage of stained (dead) and unstained (vital) spermatozoa.  
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ADDENDUM VII Chromomycin A3 (CMA3) staining method (Esterhuizen et al., 2000) 
 
Materials: 
 Mcllvaine’s Buffer Stock Solutions 
Solution 1: Dissolve 3.8424g citric acid (anhydrous) in 200ml distilled water 
Solution 2: Dissolve 25.5564g sodium phosphate dibasic (anhydrous) in 900ml distilled water 
 McIlvaine’s Buffer Working Solution (1L) 
Dilute 176.5ml of solution 1 with 823.5ml of solution 2 
 Chromomycin A3 
Dissolve 10mg CMA3 in 1ml ethanol  
Store at -20°C in 50µl aliquots 
Add 250µl of McIlvaine‟s buffer (working solution) to each aliquot before using 
 Fixative 
Methanol/acetic acid (3:1) 
 Dabco Anti-Fade Solution 
 
Method: 
CMA3 Staining: 
1) Prepare smears of all nine test samples (see Figure 5.3), and allowed to air dry.  
2) Fix smears for 20 minutes at room temperature in methanol/acetic acid and allow to air dry.  
The following steps must take place in the dark:  
3) Stain slides for 20 minutes with 15µl CMA3 in a dark chamber.  
4) Rinse slides in McIlvaine‟s buffer. 
Mounting: 
5) Mount slides immediately with Dabco anti-fade solution.  
6) Cover slides with coverslips; the occurrence of air bubbles must be avoided.  
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7) Store slides at room temperature in a dark chamber overnight and evaluate the next morning. 
 
Evaluation: 
8) Evaluate slides using a fluorescence microscope with 100x oil immersion phase contrast 
objective.  
9) Evaluate one hundred spermatozoa on each slide. The percentage bright yellow stained 
spermatozoa must be counted as CMA3 positive cells. These spermatozoa are regarded as 
cells with poor chromatin packaging quality. Poor chromatin packaging quality in the sperm 
head are indicated by:  
 faintly yellow fluorescent staining  
 bright yellow fluorescent staining  
Dull yellow stained spermatozoa must be counted as CMA3 negative cells. These spermatozoa 
are regarded as cells that contain good chromatin packaging. Good chromatin packaging 
quality in the sperm head are indicated by:  
 no fluorescent staining 
 fluorescence band at equatorial segment 
 fluorescent stain around periphery of head (stain did not permeate membrane) 
(Esterhuizen et al., 2000) 
10)  Annotate the percentage of CMA3 positive cells and classify sperm samples as mature (good) 
versus immature (poor) DNA packaging spermatozoa.  
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ADDENDUM VIII Terminal deoxynucleotidyl transferase dUTP nick-end labelling (TUNEL) 
assaymethod –  Epi-fluorescence (modified from Avendaño et al., 2010) 
 
Materials:  
 PBS solution  
Dissolve one phosphate buffered saline tablet in 1l distilled water  
 4% formaldehyde/PBS solution 
Mix 1ml formaldehyde with 9ml PBS (phosphate buffered saline) 
 1% HSA/PBS 
Mix 0.1ml HSA (human serum albumin) in 9.9ml PBS 
 0.1% Triton X-100/PBS 
Mix 0.01ml Triton X-100 in 9.9ml PBS 
 TUNEL reaction mixture 
Thaw 2 vials (enzyme and label solution) from the Roche In Situ Cell Death Detection Kit, 
Fluorescein. Aliquot 10µl enzyme solution and 95µl labelling solution into a total of ten 
Eppendorf tubes (respectively). Label the tubes and refreeze all the tubes. Remember that 
these solutions must always be kept in the dark. During the staining method, mix enzyme/label 
(1:9) solution that will serve as the TUNEL reaction mixture.  
 Dabco Anti-Fade Solution  
 
Method: 
Sample collecting: 
1) Freeze an aliquote (≥30µl) of each of the nine test sperm solutions after each time interval in 
pipette tips (see Figure 5.4) by dunking it directly into liquid nitrogen.  
2) Store the samples in a nitrogen tank specifically reserved for experimental samples only.  
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Figure 5.4     Photograph of pipette tips used to freeze sperm test sample for TUNEL analysis.   
(Photo by M Nel) 
 
Sample preparation:  
3) Thaw 20 test sample solutions for 10 minutes at 37°C. 
4) Aliquot the 20 samples onto two duplicate 21 well Teflon printed diagnostic slides (see Figure 
5.5). The 21st well will serve as a negative control. The extra duplicate slide will be used if the 
first slide evaluations were not effective.  
5) Allow the slides to air dry.  
 
 
 
Figure 5.5    Teflon Printed diagnostic slide with negative control well indicated in red.  
(Available at: http://www.2spi.com/catalog/new/ptfesld.shtml) 
 
 
TUNEL staining:  
6) Add 5µl of 4% formaldehyde/PBS to each well of one slide and incubate for 45 minutes at 
room temperature in a humidified chamber.  
7) Siphon the fluid from all the wells.  
8) Add 10µl of 1% HSA/PBS to each well and siphon the fluid after about 2 minutes. This will 
serve as a washing step. 
Stellenbosch University  https://scholar.sun.ac.za
127 
 
9) Add 5µl of 0.1% Triton X-100/PBS to each well and incubate for 10 minutes at room 
temperature in a humidified chamber.  
10) Siphon the fluid from all the wells.  
11) Wash the wells twice (see step 8). 
The following steps must take place in the dark:  
12) During the last 2 minute washing step, thaw 2 Eppendorf tubes (enzyme and label solution) 
previously aliquoted.  
13) Add 5µl label solution to the negative control well.  
14) Mix the remaining label solution (90µl) to the 5µl thawed enzyme solution.  
15) Add 5µl of the TUNEL reaction mixture to the remaining 20 wells. 
16) Incubate the slide for an hour and a half in a dark humidified chamber at 37°C.  
17) Siphon the fluid from all the wells.  
18) Wash the wells twice (see step 8). 
19) Add Dabco anti-fade solution to the wells, cover the slide with a coverslip and evaluate 
immediately.  
Evaluation: 
20) Evaluate slides using a fluorescence microscope with 100x oil immersion phase contrast 
objective. Use an excitation wavelength in the range of 450 – 500nm and detection in the 
range of 515 – 565nm (green).  
21) Evaluate one hundred spermatozoa on each well. The percentage green fluorescent stained 
spermatozoa must be counted as TUNEL positive cells. These spermatozoa are regarded as 
cells with DNA fragmentation/damage. Spermatozoa with no fluorescent staining must be 
counted as TUNEL negative cells. These spermatozoa are regarded as cells that contain 
intact DNA.  
22) Annotate the percentage of TUNEL positive cells.  
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ADDENDUM IX Data sheet 
Date      
  
P S C 
Patient name      
     
Patient sample number   
     
          
   
Before 
S/U 
After 
S/U   
  
  
Volume (ml)         
 
Time passed   
Viscosity (cm)      
 
Time analysed   
Count (x 106 / ml)       
 
Time S/U fin   
Motility (%)         
  
  
  
FP         
  
  
  
Cells         
  
  
  
Agglutination         
 
Volume to resuspend 
(µl) 
  
    
  
  
  
  
MOTILITY and KINEMATIC MEASUREMENTS 
   
 
p1 p2 p3 s1 s2 s3 c1 c2 c3 
Motility (%)                   
Progressive 
(%) 
                  
VAP (µm/s)                   
VSL (µm/s)                   
VCL (µm/s)                   
ALH (µm)                   
BCF (Hz)                   
STR (%)                   
LIN (%)                   
Comments                    
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VIABILITY  
        
 
p1 p2 p3 s1 s2 s3 c1 c2 c3 
Viable 
sperm cells 
(%) 
                  
Comments                    
                    
          
          
CMA3 
         
 
p1 p2 p3 s1 s2 s3 c1 c2 c3 
CMA3 
positive 
sperm (%) 
                  
Comments                   
                    
          
          
TUNEL 
         
 
p1 p2 p3 s1 s2 s3 c1 c2 c3 
TUNEL 
positive 
sperm (%) 
                  
Comments                   
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ADDENDUM X Summary of sperm parameters of donors  
 
Table 5.2  Summary of sperm parameters of donors used with reference to the WHO (2010).  
Semen parameter 
WHO (2010) lower 
reference limit 
Exclusion criteria of 
study 
Average sperm 
parameters of 
donors used  
Volume (ml) 1.5 < 1 2.3 
Viscosity (cm) > 2 ≥ 10 0.6 
Motility (%) 40 < 40 55.9 
Forward progression * < 2+ forward progression 3- 
Concentration (10
6
/ml) 
15 < 50 91.8 
 
* The previous edition of this manual recommended that progressively motile spermatozoa should be 
categorized as rapid or slow, with a speed of >25 μm/sec at 37 °C defining “grade a” spermatozoa. 
However, it is difficult for technicians to define the forward progression so accurately without bias 
(Cooper and Yeung, 2006).  
 
Although the exclusion criteria is not in accordance with the WHO (2010) reference values, the criteria 
were chosen in order to obtain an ideal swim up concentration of ≥20x106/ml.  
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ADDENDUM XI Statistical analysis results   
 
Sperm viability 
 
. by time, sort : tabstat vs , statistics( mean sd min p25 p50 p75 max    ) by(method) varwidth(8) 
colum 
>ns(statistics) nototal 
--------------------------------------------------------------------------------------- 
 
medium variable |     mean        sd       min       p25       p50       p75       max 
----------------+---------------------------------------------------------------------- 
->time = 5     | 
PVO          vs |  68.42222  13.17981        31        59        69        79        91 
SPS          vs |  62.74444  14.10599        24        53        63        74        91 
SPW          vs |  64.13333  12.54314        26        56      66.5        74        88 
->time = 30    | 
PVO          vs |  67.42222  13.33491        28        58      68.5        77        89 
SPS          vs |  61.18889   12.8342        33        52      60.5        70        90 
SPW          vs |  62.38889  12.59454        27        53        63        71        93 
->time = 60    | 
PVO          vs |  63.02222  14.59643        25        53      63.5        75        87 
SPS          vs |  59.44444  12.95117        28        49        60        71        81 
SPW          vs |  58.88889  12.55858        31        49      59.5        69        81 
--------------------------------------------------------------------------------------- 
 
Models 
 
1. Interaction between time and medium 
 
. test _ItimXmet_2_2 _ItimXmet_2_3 _ItimXmet_3_2 _ItimXmet_3_3 
( 1)  _ItimXmet_2_2 = 0 
( 2)  _ItimXmet_2_3 = 0 
( 3)  _ItimXmet_3_2 = 0 
( 4)  _ItimXmet_3_3 = 0 
chi2(  4) =    3.16 
         Prob > chi2 =    0.5320 
 
 
2. Contrast between control (Sperm Washing) and active mediums (PVP& SpermSlow)  
 
xi: binreg vs b3.method i.time , rd n(n) vce(cluster id) 
i.time            _Itime_1-3          (naturally coded; _Itime_1 omitted) 
Generalized linear models                          No. of obs      =       810 
Optimization     : MQL Fisher scoring              Residual df     =       805 
                   (IRLS EIM)                      Scale parameter =         1 
Deviance         =  6212.112098                    (1/df) Deviance =  7.716909 
Pearson          =  6042.957493                    (1/df) Pearson  =  7.506779 
Variance function: V(u) = u*(1-u/n)                [Binomial] 
Link function    : g(u) = u/n                      [Identity] 
                                                   BIC             =  820.9995 
                                    (Std. Err. adjusted for 90 clusters in id) 
------------------------------------------------------------------------------ 
             |             Semirobust 
vs | Risk Diff.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
method | 
PVP  |   .0449073   .0085113     5.28   0.000     .0282256    .0615891 
SPS  |  -.0069281   .0074057    -0.94   0.350    -.0214429    .0075868 
             | 
    _Itime_2 |  -.0142496   .0067652    -2.11   0.035    -.0275092     -.00099 
    _Itime_3 |  -.0466244   .0082645    -5.64   0.000    -.0628225   -.0304263 
       _cons |   .6383719   .0127914    49.91   0.000     .6133013    .6634425 
------------------------------------------------------------------------------ 
. test _Itime_2 _Itime_3 
( 1)  _Itime_2 = 0 
( 2)  _Itime_3 = 0 
chi2(  2) =   32.02 
         Prob > chi2 =    0.0000 
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3. Equivalence between two active mediums 
 
xi: binreg vs i.method i.time , rd n(n) vce(cluster id) 
i.method          _Imethod_1-3        (naturally coded; _Imethod_1 omitted) 
i.time            _Itime_1-3          (naturally coded; _Itime_1 omitted) 
Generalized linear models                          No. of obs      =       810 
Optimization     : MQL Fisher scoring              Residual df     =       805 
                   (IRLS EIM)                      Scale parameter =         1 
Deviance         =  6212.112098                    (1/df) Deviance =  7.716909 
Pearson          =  6042.957493                    (1/df) Pearson  =  7.506779 
Variance function: V(u) = u*(1-u/n)                [Binomial] 
Link function    : g(u) = u/n                      [Identity] 
                                                   BIC             =  820.9995 
                                    (Std. Err. adjusted for 90 clusters in id) 
------------------------------------------------------------------------------ 
             |             Semirobust 
vs | Risk Diff.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
  _Imethod_2 |  -.0518354    .007858    -6.60   0.000    -.0672367    -.036434 
  _Imethod_3 |  -.0449073   .0085113    -5.28   0.000    -.0615891   -.0282256 
    _Itime_2 |  -.0142496   .0067652    -2.11   0.035    -.0275092     -.00099 
    _Itime_3 |  -.0466244   .0082645    -5.64   0.000    -.0628225   -.0304263 
       _cons |   .6832793   .0136328    50.12   0.000     .6565595     .709999 
------------------------------------------------------------------------------ 
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CMA3 analysis  
 
 
. by time, sort : tabstat cma , statistics( mean sd min p25 p50 p75 max    ) by(method) varwidth(8) 
colu 
>mns(statistics) nototal 
---------------------------------------------------------------------------------------- 
 
medium variable |      mean        sd       min       p25       p50       p75       max 
----------------+---------------------------------------------------------------------- 
->time = 5      
----------------+---------------------------------------------------------------------- 
PVP         cma |  17.52222  8.890378         2        12      16.5        22        58 
SPS         cma |  16.83333  8.968422         2        10        16        21        45 
SPW         cma |  16.87778  8.188547         1        11        16        20        45 
--------------------------------------------------------------------------------------- 
->time = 30 
----------------+---------------------------------------------------------------------- 
PVP         cma |  18.18889  8.073948         4        14      17.5        23        41 
SPS         cma |  17.23333  8.920435         2        11        16        22        42 
SPW         cma |  17.95556  8.343619         1        12        17        22        41 
--------------------------------------------------------------------------------------- 
->time = 60 
----------------+---------------------------------------------------------------------- 
PVP         cma |      19.1  9.354504         4        13      17.5        23        48 
SPS         cma |  17.11111  8.130183         1        12        16        21        45 
SPW         cma |  17.05556  8.447273         2        11      15.5        22        43 
--------------------------------------------------------------------------------------- 
 
Models 
 
1. Interaction between time and medium  
 
. test _ItimXmet_2_2 _ItimXmet_2_3 _ItimXmet_3_2 _ItimXmet_3_3 
( 1)  _ItimXmet_2_2 = 0 
( 2)  _ItimXmet_2_3 = 0 
( 3)  _ItimXmet_3_2 = 0 
( 4)  _ItimXmet_3_3 = 0 
chi2(  4) =    6.29 
         Prob > chi2 =    0.1787 
 
 
2. Contrast between control (Sperm Washing) and active mediums (PVP& SpermSlow)  
. xi: binreg cma b3.method i.time , rd n(n) vce(cluster id) 
i.time            _Itime_1-3          (naturally coded; _Itime_1 omitted) 
Generalized linear models                          No. of obs      =   810 
Optimization     : MQL Fisher scoring              Residual df     =       805 
                   (IRLS EIM)                      Scale parameter =         1 
Deviance         =  4106.459126                    (1/df) Deviance =  5.101191 
Pearson          =  4106.163228                    (1/df) Pearson  =  5.100824 
Variance function: V(u) = u*(1-u/n)                [Binomial] 
Link function    : g(u) = u/n                      [Identity] 
                                                   BIC             = -1284.653 
                                    (Std. Err. adjusted for 90 clusters in id) 
------------------------------------------------------------------------------ 
             |             Semirobust 
cma | Risk Diff.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
method | 
PVP  |   .0097143   .0054169     1.79   0.073    -.0009025    .0203312 
SPS  |  -.0023465   .0048598    -0.48   0.629    -.0118716    .0071786 
             | 
    _Itime_2 |   .0071409   .0040785     1.75   0.080    -.0008528    .0151346 
    _Itime_3 |   .0066357   .0040568     1.64   0.102    -.0013154    .0145868 
       _cons |   .1683719   .0079709    21.12   0.000     .1527493    .1839945 
------------------------------------------------------------------------------ 
. test _Itime_2 _Itime_3 
( 1)  _Itime_2 = 0 
( 2)  _Itime_3 = 0 
chi2(  2) =    3.77 
         Prob > chi2 =    0.1515 
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3. Equivalence between two active mediums 
 
. xi: binreg cma i.method i.time , rd n(n) vce(cluster id) 
i.method          _Imethod_1-3        (naturally coded; _Imethod_1 omitted) 
i.time            _Itime_1-3          (naturally coded; _Itime_1 omitted) 
Generalized linear models                          No. of obs      =       810 
Optimization     : MQL Fisher scoring              Residual df     =       805 
                   (IRLS EIM)                      Scale parameter =         1 
Deviance         =  4106.459126                    (1/df) Deviance =  5.101191 
Pearson          =  4106.163228                    (1/df) Pearson  =  5.100824 
Variance function: V(u) = u*(1-u/n)                [Binomial] 
Link function    : g(u) = u/n                      [Identity] 
                                                   BIC             = -1284.653 
                                    (Std. Err. adjusted for 90 clusters in id) 
------------------------------------------------------------------------------ 
             |             Semirobust 
cma | Risk Diff.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
  _Imethod_2 |  -.0120609   .0052848    -2.28   0.022    -.0224188   -.0017029 
  _Imethod_3 |  -.0097143   .0054169    -1.79   0.073    -.0203312    .0009025 
    _Itime_2 |   .0071409   .0040785     1.75   0.080    -.0008528    .0151346 
    _Itime_3 |   .0066357   .0040568     1.64   0.102    -.0013154    .0145868 
       _cons |   .1780863   .0087013    20.47   0.000      .161032    .1951405 
------------------------------------------------------------------------------ 
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TUNEL analysis  
 
 
. by time, sort : tabstat tun , statistics( mean sd min p25 p50 p75 max    ) by(method) varwidth(8) 
colu 
>mns(statistics) nototal 
--------------------------------------------------------------------------------------- 
->time = 30 
 
method variable |      mean        sd       min       p25       p50       p75       max 
----------------+---------------------------------------------------------------------- 
PVP         tun |  11.62069  7.775482         2         6        10        15        38 
SPS         tun |  12.06897  5.541603         3         8        11        15        29 
SPW         tun |  11.86207  7.361697         3         6         9        14        34 
--------------------------------------------------------------------------------------- 
->time = 60 
 
method variable |      mean        sd       min       p25       p50       p75       max 
----------------+---------------------------------------------------------------------- 
PVP         tun |  10.89655  6.189535         2         7        10        12        28 
SPS         tun |  13.44828  7.467005         5         7        12        17        35 
SPW         tun |   11.7931  6.678212         3         8        10        15        35 
--------------------------------------------------------------------------------------- 
 
Models 
 
1. Interaction between time and medium 
 
. test _ItimXmet_2_2 _ItimXmet_2_3 _ItimXmet_3_2 _ItimXmet_3_3 
( 1)  _ItimXmet_2_2 = 0 
( 2)  _ItimXmet_2_3 = 0 
( 3)  o._ItimXmet_3_2 = 0 
( 4)  o._ItimXmet_3_3 = 0 
       Constraint 3 dropped 
       Constraint 4 dropped 
chi2(  2) =    1.85 
         Prob > chi2 =    0.3959 
 
 
 
2. Contrast between control (Sperm Washing) and active mediums (PVP& SpermSlow)  
 
xi: binreg tun b3.method b2.time , rd n(n) vce(cluster id) 
Iteration 5:   deviance =  695.2197 
Generalized linear models                          No. of obs      =       174 
Optimization     : MQL Fisher scoring              Residual df     =       170 
                   (IRLS EIM)                      Scale parameter =         1 
Deviance         =   695.219654                    (1/df) Deviance =  4.089527 
Pearson          =  762.9021553                    (1/df) Pearson  =   4.48766 
Variance function: V(u) = u*(1-u/n)                [Binomial] 
Link function    : g(u) = u/n                      [Identity] 
                                                   BIC             = -181.8197 
                                    (Std. Err. adjusted for 29 clusters in id) 
------------------------------------------------------------------------------ 
             |             Semirobust 
tun | Risk Diff.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
method | 
PVP  |  -.0056693   .0054591    -1.04   0.299    -.0163689    .0050302 
SPS  |   .0092718   .0063587     1.46   0.145    -.0031912    .0217347 
             | 
time | 
60  |   .0015699   .0060185     0.26   0.794    -.0102262     .013366 
       _cons |   .1174974   .0132298     8.88   0.000     .0915675    .1434274 
------------------------------------------------------------------------------ 
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3. Equivalence between two active mediums 
 
. xi: binreg tun i.method i.time , rd n(n) vce(cluster id) 
i.method          _Imethod_1-3        (naturally coded; _Imethod_1 omitted) 
i.time            _Itime_1-3          (naturally coded; _Itime_1 omitted) 
note: _Itime_3 omitted because of collinearity 
Generalized linear models                          No. of obs      =       174 
Optimization     : MQL Fisher scoring              Residual df     =       170 
                   (IRLS EIM)                      Scale parameter =         1 
Deviance         =   695.219654                    (1/df) Deviance =  4.089527 
Pearson          =  762.9021553                    (1/df) Pearson  =   4.48766 
Variance function: V(u) = u*(1-u/n)                [Binomial] 
Link function    : g(u) = u/n                      [Identity] 
                                                   BIC             = -181.8197 
                                    (Std. Err. adjusted for 29 clusters in id) 
------------------------------------------------------------------------------ 
             |             Semirobust 
tun | Risk Diff.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
  _Imethod_2 |   .0149411   .0064618     2.31   0.021     .0022761    .0276061 
  _Imethod_3 |   .0056693   .0054591     1.04   0.299    -.0050302    .0163689 
    _Itime_2 |  -.0015699   .0060185    -0.26   0.794     -.013366    .0102262 
       _cons |   .1133979   .0125166     9.06   0.000     .0888659      .13793 
------------------------------------------------------------------------------ 
  
Stellenbosch University  https://scholar.sun.ac.za
137 
 
CASA Analysis – Sperm motility 
 
. by time, sort : tabstat mot , statistics( mean sd min p25 p50 p75 max    ) by(method) varwidth(8) 
columns(statistics) nototal 
 
->time = 5 
 
method variable | mean     sd       min       p25       p50       p75       max 
----------------+---------------------------------------------------------------- 
PVP   mot |  73.59667  13.99066      37.4      67.5     77.35        84        94 
SPS   mot |  73.58556  14.21284      34.4      66.1     77.25      83.4        98 
SPW   mot |  74.43889  13.71803      32.8      65.9      77.6      85.2        96 
--------------------------------------------------------------------------------- 
->time = 30 
 
method variable | mean     sd       min       p25       p50       p75       max 
----------------+---------------------------------------------------------------- 
PVP  mot |  73.57667  13.56704      35.3      65.4     75.05      84.3        98 
SPS  mot |  74.03333  13.64179      37.7      66.5     78.15      82.7        96 
SPW  mot |  77.05667  13.56274      33.7      70.7      80.1      86.5      95.7 
--------------------------------------------------------------------------------- 
->time = 60 
method variable | mean   sd       min       p25       p50       p75       max 
----------------+---------------------------------------------------------------- 
PVP   mot |  68.70444  15.17682       3.2      61.9      70.7        80        90 
SPS   mot |  70.82556  14.11112      31.3        64     73.05      81.6        97 
SPW   mot |  75.76778  12.86855      37.8      69.5     77.85      86.1        94 
--------------------------------------------------------------------------------- 
 
Models 
 
1. Interaction between time and medium 
 
test _ItimXmet_2_2 _ItimXmet_2_3 _ItimXmet_3_2 _ItimXmet_3_3 
 
( 1)  [mot]_ItimXmet_2_2 = 0 
( 2)  [mot]_ItimXmet_2_3 = 0 
( 3)  [mot]_ItimXmet_3_2 = 0 
( 4)  [mot]_ItimXmet_3_3 = 0 
chi2(  4) =   21.12 
         Prob > chi2 =    0.0003 
 
 
2. Contrast between control (Sperm Washing) and PVP  
 
a) 5 minute incubation  
. lincom _Imethod1_2 
( 1)  [mot]_Imethod1_2 = 0 
------------------------------------------------------------------------------ 
mot |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         (1) |  -.8422222   .6953636    -1.21   0.226     -2.20511    .5206654 
------------------------------------------------------------------------------ 
 
b) 30 minute incubation  
. lincom _Imethod1_2+ _ItimXmet_2_2 
( 1)  [mot]_Imethod1_2 + [mot]_ItimXmet_2_2 = 0 
------------------------------------------------------------------------------ 
mot |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         (1) |      -3.48   .9594203    -3.63   0.000    -5.360429   -1.599571 
------------------------------------------------------------------------------ 
 
c) 60 minute incubation  
. lincom _Imethod1_2 +_ItimXmet_3_2 
( 1)  [mot]_Imethod1_2 + [mot]_ItimXmet_3_2 = 0 
------------------------------------------------------------------------------ 
mot |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         (1) |  -7.063333   1.273402    -5.55   0.000    -9.559155   -4.567512 
------------------------------------------------------------------------------ 
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3. Contrast between control (Sperm Washing) and SpermSlow  
a) 5 minute incubation  
. lincom _Imethod1_3 
( 1)  [mot]_Imethod1_3 = 0 
------------------------------------------------------------------------------ 
mot |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         (1) |  -.8533336   .7532272    -1.13   0.257    -2.329632    .6229647 
------------------------------------------------------------------------------ 
 
b) 30 minute incubation  
. lincom _Imethod1_3+ _ItimXmet_2_3 
( 1)  [mot]_Imethod1_3 + [mot]_ItimXmet_2_3 = 0 
------------------------------------------------------------------------------ 
mot |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         (1) |  -3.023333   .8428713    -3.59   0.000    -4.675331   -1.371336 
------------------------------------------------------------------------------ 
 
c) 60 minute incubation  
. lincom _Imethod1_3+ _ItimXmet_3_3 
( 1)  [mot]_Imethod1_3 + [mot]_ItimXmet_3_3 = 0 
------------------------------------------------------------------------------ 
mot |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         (1) |  -4.942222   1.127948    -4.38   0.000     -7.15296   -2.731484 
------------------------------------------------------------------------------ 
 
 
 
 
4. Equivalence between two active mediums 
 
a) 5 minute incubation  
. lincom _Imethod_2 
( 1)  [mot]_Imethod_2 = 0 
------------------------------------------------------------------------------ 
mot |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         (1) |  -.0111114   .7014137    -0.02   0.987    -1.385857    1.363634 
------------------------------------------------------------------------------ 
 
a) 30 minute incubation  
. lincom _Imethod_2+ _ItimXmet_2_2 
( 1)  [mot]_Imethod_2 + [mot]_ItimXmet_2_2 = 0 
------------------------------------------------------------------------------ 
mot |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         (1) |   .4566667   .9059025     0.50   0.614     -1.31887    2.232203 
------------------------------------------------------------------------------ 
 
 
a) 60 minute incubation  
. lincom _Imethod_2+ _ItimXmet_3_2 
( 1)  [mot]_Imethod_2 + [mot]_ItimXmet_3_2 = 0 
mot |      Coef.   Std. Err.      Z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         (1) |   2.121111   1.152814     1.84   0.066    -.1383627    4.380585 
------------------------------------------------------------------------------ 
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CASA Analysis – Progressive sperm motility 
 
 
by time, sort : tabstat prog , statistics( mean sd min p25 p50 p75 max    ) by(method) varwidth(8) 
columns(statistics) nototal 
--------------------------------------------------------------------------------------- 
method variable |      mean        sd       min       p25       p50       p75       max 
----------------+---------------------------------------------------------------------- 
->time = 5 
PVP        prog |  51.40111  18.53655      12.4        34      54.7        66      89.5 
SPS        prog |  53.86333  18.09419      11.5      39.7      57.9      69.3      82.2 
SPW        prog |  52.11778  17.79094      14.5        40      53.6      66.6      90.1 
->time = 30 
PVP        prog |  58.65333  13.93976        23      50.4      61.5      68.3      86.3 
SPS        prog |  59.16778   14.4915      24.7      50.1     61.05      70.4      85.8 
SPW        prog |  60.99556   13.5057      28.3      50.1     62.05        73        85 
->time = 60 
PVP        prog |  54.47444  13.00238      23.2        46      54.8        64      80.8 
SPS        prog |     56.16   14.0835      26.1        46     57.75      67.2      82.6 
SPW        prog |  59.43556   14.5128      28.5      47.8     61.15      69.8      88.5 
--------------------------------------------------------------------------------------- 
 
Models 
 
1. Interaction between time and medium 
 
. test _ItimXmet_2_2 _ItimXmet_2_3 _ItimXmet_3_2 _ItimXmet_3_3 
( 1)  [prog]_ItimXmet_2_2 = 0 
( 2)  [prog]_ItimXmet_2_3 = 0 
( 3)  [prog]_ItimXmet_3_2 = 0 
( 4)  [prog]_ItimXmet_3_3 = 0 
chi2(  4) =   21.50 
         Prob > chi2 =    0.0003 
 
 
 
2. Contrast between control (Sperm Washing) and PVP  
 
a) 5 minute incubation  
. lincom _Imethod1_2 
( 1)  [prog]_Imethod1_2 = 0 
------------------------------------------------------------------------------ 
prog |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         (1) |  -.7166667     .99188    -0.72   0.470    -2.660716    1.227382 
------------------------------------------------------------------------------ 
 
 
b) 30 minute incubation  
. lincom _Imethod1_2+ _ItimXmet_2_2 
( 1)  [prog]_Imethod1_2 + [prog]_ItimXmet_2_2 = 0 
------------------------------------------------------------------------------ 
prog |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         (1) |  -2.342222   1.135542    -2.06   0.039    -4.567844   -.1166008 
------------------------------------------------------------------------------ 
 
 
c) 60 minute incubation  
. lincom _Imethod1_2 +_ItimXmet_3_2 
( 1)  [prog]_Imethod1_2 + [prog]_ItimXmet_3_2 = 0 
prog |      Coef.   Std. Err.      Z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         (1) |  -4.961111   1.052442    -4.71   0.000     -7.02386   -2.898362 
------------------------------------------------------------------------------ 
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3. Contrast between control (Sperm Washing) and SpermSlow  
 
a) 5 minute incubation  
. lincom _Imethod1_3 
( 1)  [prog]_Imethod1_3 = 0 
------------------------------------------------------------------------------ 
prog |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         (1) |   1.745556     1.1155     1.56   0.118     -.440784    3.931895 
------------------------------------------------------------------------------ 
 
b) 30 minute incubation  
. lincom _Imethod1_3+ _ItimXmet_2_3 
( 1)  [prog]_Imethod1_3 + [prog]_ItimXmet_2_3 = 0 
------------------------------------------------------------------------------ 
prog |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         (1) |  -1.827778   .9093028    -2.01   0.044    -3.609978   -.0455771 
------------------------------------------------------------------------------ 
 
c) 60 minute incubation  
. lincom _Imethod1_3+ _ItimXmet_3_3 
( 1)  [prog]_Imethod1_3 + [prog]_ItimXmet_3_3 = 0 
------------------------------------------------------------------------------ 
prog |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         (1) |  -3.275556   1.075053    -3.05   0.002     -5.38262   -1.168491 
------------------------------------------------------------------------------ 
 
 
 
 
 
4. Equivalence between two active mediums 
 
a) 5 minute incubation  
. lincom _Imethod_2 
( 1)  [mot]_Imethod_2 = 0 
------------------------------------------------------------------------------ 
mot |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         (1) |  -.0111114   .7014137    -0.02   0.987    -1.385857    1.363634 
------------------------------------------------------------------------------ 
 
b) 30 minute incubation  
. lincom _Imethod_2+ _ItimXmet_2_2 
( 1)  [mot]_Imethod_2 + [mot]_ItimXmet_2_2 = 0 
------------------------------------------------------------------------------ 
mot |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         (1) |   .4566667   .9059025     0.50   0.614     -1.31887    2.232203 
------------------------------------------------------------------------------ 
 
c) 60 minute incubation  
. lincom _Imethod_2+ _ItimXmet_3_2 
( 1)  [mot]_Imethod_2 + [mot]_ItimXmet_3_2 = 0 
------------------------------------------------------------------------------ 
mot |      Coef.   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
         (1) |   2.121111   1.152814     1.84   0.066    -.1383627    4.380585 
------------------------------------------------------------------------------ 
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ADDENDUM XII Holding solutions‟ specifications (from product leaflet) 
 
Table 5.3 Table of PVP and SpermSlowTM holding solutions‟ specifications. 
 PVP SpermSlow
TM
 
Usage 
For slowing down the movement of 
spermatozoa for ICSI.  
For slowing down the movement of the 
sperm to allow for the selection of the mist 
mature, viable spermatozoa for ICSI.  
Components 
polyvinylpyrrolidone, HEPES-HTF, 
human serum albumin 
water, sodium hyaluronate, human serum 
albumin, sodium chloride, amino acids, 
glucose, sodium bicarbonate, disodium 
hydrogen phosphate, porassium chloride, 
sodium pyruvate, nucleotides, calcium 
chloride, magnesium sulphate, vitamins, 
hydrochloric acid, sodium phosphate, 
calcium lactate, sodium citrate, potassium 
phosphate, L-malic acid, sodium acetate, 
human insulin recombinant, synthetic 
cholesterol, gentamicin sulphate 
Appearance Pink-rose color  Clear, colorless liquid 
Odor Odorless Odorless 
Solubility H2O Soluble Soluble 
Storage 
requirements  
Store in original container at 2-8°C, 
protected from light and oxidizing 
agents. Do not freeze.  
Store in original container at 2-8°C, 
protected from light. Do not freeze.  
Shelf-life 12 months 12 weeks (minimum) 
Cost per ml R 2 538.00 R 6 682.50  
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Directions  
for use  
1. Remove PVP ready to use solution 
from storage at 2-8°C and leave at 
room temperature for 10 minutes.  
2. Depending on the number of 
oocytes for injection, pipette a 
corresponding number of 10 µl 
droplets of holding medium onto the 
bottom of the ICSI dish.  
3. In the middle of the same dish place 
a 5-10 µl droplet of PVP ready to use 
solution.  
4. Cover with pre-equilibrated liquid 
paraffin and place the dish in a 5-6% 
CO2 environment at 37°C for 30 
minutes prior to use.  
5. Introduce 2 µl of prepared and 
washed sperm to the droplet of PVP 
ready to use solution. The PVP will 
reduce the motility of the sperm and 
facilitate the capture and loading of a 
single spermatozoon in the injection 
pipette.  
1. Remove SpermSlow™ and preferred 
holding medium from storage at 2-8°C 
and leave at room temperature for 10 
minutes.  
2. Pipette 2x 10μl of SpermSlow™ onto 
the bottom of the ICSI dish, which should 
be kept at 37°C during the whole 
procedure (1 drop in centre, 1 drop at the 
rim of the dish).  
3. Depending on the number of oocytes 
used in the ICSI procedure, pipette a 
corresponding number of 5-10μl droplets 
of holding medium.  
4. Introduce a small amount e.g. 1-5 μl of 
prepared and washed sperm close to the 
SpermSlow™ drop in the centre of the 
ICSI dish.  
5. Use the pipette tip to create a junction 
between the sperm droplet and the 
SpermSlow™ drop in the centre.  
6. Immediately cover the ICSI dish with 
pre-equilibrated Liquid Paraffin and place 
it in a 5-6% CO2 incubator at 37°C for 15 
minutes prior to use.  
7. Wash/rinse the injection pipette in pre-
equilibrated Sperm Preparation Medium. 
Aspirate 10-20 mm into the holding pipette 
and 2-5 mm into the injection pipette  
8. After 1 minute expel the Sperm 
Preparation Medium from the injection 
pipette into the dish with the Sperm 
Preparation Medium. The injection pipette 
is now coated to avoid sperm and 
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SpermSlow™ adhering to the needle.  
9. Place an oocyte in each droplet of 
holding medium.  
10. Aspirate 5-6 mm SpermSlow™ from 
the SpermSlow™ drop at the rim of the 
ICSI dish.  
11. Carefully select a mature 
spermatozoon from near the junction 
between the sperm droplet and the 
SpermSlow™ drop. Mature spermatozoa 
will be bound to the Hyaluronate in 
SpermSlow™. Therefore, look for the 
spermatozoon with the best morphology, 
and which has a moving tail but no 
forward motion (i.e. is „moving in place‟).  
Spermatozoa moving freely in the 
SpermSlow™ drop are immature 
spermatozoa and should not be selected.  
Incubation 
requirements  
Incubate 5-10 µl droplet of PVP ready 
to use solution onto the bottom of the 
ICSI dish, cover with liquid paraffin and 
place it in a 5-6% CO2 environment at 
37°C for 30 minutes prior to use.  
Incubate  2x 10μl of SpermSlow™ onto 
the bottom of the ICSI dish, cover with 
liquid paraffin and place it in a 5-6% CO2 
incubator at 37°C for 15 minutes prior to 
use. 
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ADDENDUM XIII Chemicals used during experiment 
 
Table 5.4 List of suppliers of the chemicals used in the study. 
 Chemical  Supplier  
Catalog 
number 
Semen sample preparation  
and handling 
Quinn‟s Sperm 
Washing Medium 
SAGE, Cooper Surgical, 
Harrilabs, Paulshof, 
South Africa 
ART-1006 
PVP 7% Ready-to-Use 
Solution  
SAGE, Cooper Surgical, 
Harrilabs, Paulshof, 
South Africa 
ART-4005-A 
SpermSlow
TM
 
Origio, Cooper Surgical, 
Harrilabs, Paulshof, 
South Africa 
10944000 
Experiment A 
Viability stain 
Eosin 
Merck, Modderfontein, 
Gauteng, South Africa 
1159350025 
Nigrosin 
Merck, Modderfontein, 
Gauteng, South Africa 
1159240025 
CMA3 stain 
Methanol 
Merck, Modderfontein, 
Gauteng, South Africa 
8222832500 
Acetic acid 
Merck, Modderfontein, 
Gauteng, South Africa 
1990619025 
Citric acid 
Sigma-Aldrich, 
Johannesburg, South 
Africa 
C2404-500G 
Sodium phosphate 
dibasic 
Sigma-Aldrich, 
Johannesburg, South 
Africa 
S7907-500G 
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Chromomycin A3 from 
Streptomyces griseus  
Sigma-Aldrich, 
Johannesburg, South 
Africa 
C2659 – 
10MG 
Ethanol 
Merck, Modderfontein, 
Gauteng, South Africa 
1070172511 
Dabco 33-LV 
Sigma-Aldrich, 
Johannesburg, South 
Africa 
290734 – 
100ML 
TUNEL stain 
PBS tablets - 
Calbiochem 
Merck, Modderfontein, 
Gauteng, South Africa 
524650 
Formaldehyde solution 
Merck, Modderfontein, 
Gauteng, South Africa 
103999 
Human Serum Albumin  
SAGE, Cooper Surgical, 
Harrilabs, Paulshof, 
South Africa 
ART-3003 
Triton X-100 detergent - 
Calbiochem 
Merck, Modderfontein, 
Gauteng, South Africa 
648466 
Roche In Situ Cell 
Death Detection Kit, 
Fluorescein  
Roche Diagnostics, 
Mannheim, Germany 
11684795910 
Experiment B 
Transmission 
Electron 
Microscopy 
Gluteraldehyde 25% 
aqueous solution 
Merck, Modderfontein, 
Gauteng, South Africa 
354400-500ML 
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